Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595362	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 256.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		430000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	23.7	38.3	46.6	9.1	47.6	1.8	47.1	43.7	45.8	32.7	40.7	29.5	23.7	25.1	8.8	35.9	28.8	19.1	27.9	44.7	43.2	115.1	162.2	15.7	8.6	43.1	43.5	65.3	27.0	34.0	8.8	44.9	42.6	42.0	27.4	19.7	40.6	27.9	12.2	29.4	21.0	23.6	44.8	7.0	23.6	12.3	44.0	18.3	47.6	26.5	17.1	18.1	20.9	45.2	64.9	41.9	116.6	193.4	95.5	56.4	147.8	76.1	93.4	86.5	110.5	118.6	60.7	0.0	75.5	60.0	36.1	47.1	36.5	256.2	78.8	0.1	44.6	12.3	63.1	102.1	46.3	0.2	0.0	69.0	59.2	67.3	47.7	64.2	70.0	0.0	0.0	0.1	77.1	42.1	2.6	0.3	79.4	47.5	35.2	38.9	131.8	0.0	81.2	48.4	39.4	47.2	0.0	41.1	44.7	89.0	75.2	2.7	86.1	24.8	75.6	28.8	53.1	0.1	0.1	0.4	13.4	0.2	40.6	0.7	0.2	0.1	0.1	0.0	0.2	0.8	0.2	0.1	1.8	0.6	1.2	0.6	0.1	0.1	0.0	6.4	0.0	0.4	46.6	47.6	43.7	45.8	44.7	43.2	43.1	43.5	42.6	44.8	44.0	45.2	17.6	16.0	29.3	99.3	5.0	25.9	59.5	110.0	87.0	23.6	40.6	91.1	39.9	27.1	43.5	42.3	22.9	414.1	3.7	15.2	76.3	43.5	31.4	18.7	44.3	19.1	21.7	5.2	16.0	13.8	107.8	34.0	27.0	21.4	7.0	50.4	18.9	74.6	51.1	25.2	21.5	25.9	20.3	9.4	7.6	41.7	25.4	9.1	55.2	12.2	7.5	102.1	0.0	41.7	30.0	12.6	15.6	37.2	2.0	27.5	23.4	302.1	23.4	13.6	19.7	19.4	25.8	1.0	5.1	59.2	16.1	222.3	4.6	39.3	46.4	50.4
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"BLM RecQ like helicase"	P54132	15	90717346-90816166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	0.3	0.2	0.9	3.6	1.1	5.7	0.5	2.3	0.9	0.1	0.3	1.4	1.0	0.4	0.4	0.6	0.3	0.3	0.3	0.8	1.1	0.1	0.1	0.4	6.4	1.2	1.4	0.1	0.2	0.0	0.6	1.2	1.1	0.1	1.7	2.4	7.8	0.0	0.5	0.4	1.6	0.4	1.0	1.6	1.1	2.2	0.9	7.9	0.3	0.1	6.2	1.0	0.2	1.0	13.0	14.4	20.4	12.6	0.1	0.9	14.6	9.4	3.2	11.1	13.4	11.7	10.1	35.1	5.9	2.6	14.1	20.4	25.7	7.1	15.1	19.1	20.5	36.4	14.8	3.9	0.0	33.7	17.3	0.3	0.1	10.6	4.7	1.3	7.9	16.9	32.7	9.9	11.0	7.4	28.3	14.5	22.2	24.9	4.2	25.4	39.1	14.7	2.3	18.9	14.6	14.7	8.5	11.5	4.8	18.1	7.2	23.4	3.7	8.6	13.6	9.6	21.0	6.4	30.4	39.5	5.6	25.8	15.7	1.7	0.6	2.6	1.6	0.8	2.6	4.6	1.4	2.1	0.7	2.3	1.0	1.1	0.7	3.1	1.0	0.7	3.2	0.9	0.9	1.1	2.3	0.9	0.8	1.1	1.2	1.4	1.1	1.0	0.9	1.0	0.9	3.2	8.9	1.0	12.9	0.3	0.5	0.5	0.6	3.6	1.3	1.0	7.9	0.0	4.2	0.0	2.1	5.5	6.9	2.2	1.9	1.0	2.7	1.3	1.3	2.0	0.0	18.3	0.7	0.7	6.8	1.8	3.6	1.7	13.3	8.1	2.2	0.6	5.7	0.0	8.6	1.3	0.0	7.7	1.3	1.6	0.0	7.7	0.0	7.5	2.7	1.7	10.3	58.3	2.6	1.2	0.3	0.4	20.6	0.7	0.2	0.0	5.4	7.1	0.0	0.9	1.7	17.1	12.9	2.2	0.6	1.0	10.2	0.7	4.0	0.4
BPNT1		ENSG00000162813	"3'(2'), 5'-bisphosphate nucleotidase 1"	O95861	1	220057482-220090462	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 55.5;Proximal enterocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 183.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048461	Approved		Approved	"Nuclear speckles"		NA	NA		420000	"Cluster 44: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	"Nuclear speckles"		"HPA048461: AB_2680404"	"unprognostic (6.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.19e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	16.2	20.8	6.5	18.2	7.8	4.6	20.3	7.5	9.1	18.1	7.3	37.7	43.9	13.9	13.0	14.7	17.6	21.2	17.7	7.3	6.8	31.5	25.0	17.6	34.2	7.6	6.8	17.9	7.7	21.5	10.9	13.2	7.1	13.8	32.2	15.5	17.3	11.9	9.3	10.3	45.7	18.3	7.5	14.6	19.7	14.8	6.7	17.7	20.8	11.3	44.3	15.8	9.9	10.0	37.5	30.3	22.1	17.5	40.6	33.3	35.4	48.0	25.0	42.9	38.3	40.1	70.7	183.9	64.8	33.2	19.1	26.1	45.8	42.3	34.5	68.8	51.2	33.3	34.6	48.3	23.8	90.4	29.9	31.8	20.7	61.0	25.3	28.0	35.9	54.1	62.3	18.4	43.4	21.2	51.9	24.3	18.9	32.0	37.1	36.5	62.9	54.0	55.5	49.2	40.2	33.6	60.1	71.5	43.0	22.1	56.5	31.7	54.2	25.4	19.5	36.7	60.8	31.3	81.6	85.0	22.0	33.6	56.8	20.6	9.2	6.1	12.3	10.0	9.4	20.8	12.8	12.7	10.9	16.5	15.0	11.2	1.1	14.0	9.9	13.3	14.6	9.7	6.5	7.8	7.5	9.1	7.3	6.8	7.6	6.8	7.1	7.5	6.7	10.0	9.3	28.9	23.9	3.6	12.7	3.3	12.5	22.0	3.4	13.7	9.1	6.2	10.5	11.5	23.4	14.7	10.4	13.1	11.6	55.5	13.7	18.7	2.5	10.3	7.7	7.7	19.2	5.5	8.4	15.6	14.1	7.8	7.7	9.7	3.8	12.1	7.9	12.6	9.8	6.7	10.8	14.5	32.6	7.5	3.6	3.1	9.6	7.2	10.6	1.9	8.0	10.8	15.5	10.1	13.0	18.9	28.5	13.5	10.3	6.3	56.9	29.5	14.5	12.0	13.1	5.6	8.7	15.5	11.8	8.2	5.1	25.2	9.6	25.0	17.2	12.7
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2 DNA repair associated"	P51587	13	32315086-32400268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 3.1;testis: 2.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 115.4;Spermatogonia: 85.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.0	1.3	0.0	5.8	0.5	0.0	0.0	0.2	0.2	0.7	0.5	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.3	2.1	0.1	0.1	0.1	0.1	0.0	0.0	1.0	0.1	0.1	0.8	0.0	0.2	0.0	0.0	0.7	0.5	0.3	0.1	0.9	0.6	2.7	0.2	3.1	0.2	0.0	2.0	0.5	0.2	0.1	4.7	4.0	6.0	5.0	0.6	1.4	7.0	4.8	3.1	5.5	5.0	10.6	6.0	15.9	3.2	2.1	7.6	6.1	5.5	2.9	10.5	10.5	3.1	10.3	2.5	3.5	0.1	15.4	4.9	0.2	0.0	10.3	6.9	0.4	4.5	8.1	7.0	5.5	6.4	5.1	11.8	8.3	8.3	4.9	2.3	11.4	17.3	3.0	1.4	5.4	2.4	4.6	5.9	2.4	2.2	2.2	2.9	7.3	1.3	6.3	6.8	7.0	6.7	2.0	3.3	8.0	2.7	5.7	5.8	0.0	0.3	1.5	0.5	0.7	0.1	1.7	0.4	0.4	0.3	2.2	0.5	0.4	0.8	0.5	0.8	3.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	4.4	9.6	2.6	0.0	12.4	2.5	3.3	2.5	2.2	0.0	4.3	3.3	1.9	0.0	1.8	0.0	0.0	14.1	10.5	4.8	0.0	2.5	5.2	4.4	6.3	5.5	1.2	29.5	0.7	1.6	12.7	5.8	10.7	4.6	3.8	26.9	1.4	0.8	9.5	0.0	0.5	4.4	0.0	7.5	11.0	4.4	2.1	14.4	3.6	4.7	20.1	0.3	0.0	0.0	0.6	1.2	1.8	1.2	27.8	1.2	1.0	0.6	2.9	0.0	13.1	8.3	5.3	115.4	85.6	8.0	1.3	5.5	7.9	4.2	7.8	2.3
C1orf112	FLJ10706	ENSG00000000460	"Chromosome 1 open reading frame 112"	Q9NSG2	1	169662007-169854080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 13.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 30.0;Spermatocytes: 37.1;Spermatogonia: 20.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023778, HPA024451"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA023778: AB_1848665, HPA024451: AB_1848667"	"unprognostic (4.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (9.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.65e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	1.8	1.2	0.6	3.3	0.9	9.0	2.9	1.7	0.8	2.3	0.5	2.6	1.2	2.9	1.0	2.0	1.5	1.4	1.0	0.5	0.4	1.1	2.6	1.7	6.3	1.0	0.6	2.2	1.5	13.5	1.0	3.4	0.8	1.8	4.1	5.4	1.5	2.0	0.9	2.4	1.8	2.7	0.7	2.8	1.9	10.3	0.9	11.6	1.7	1.5	7.9	3.1	1.7	1.5	32.7	17.5	21.9	11.3	3.5	4.8	32.2	21.1	10.7	30.0	30.6	19.1	27.7	29.0	9.3	7.0	10.7	26.0	27.6	14.7	34.3	16.9	16.5	27.1	23.0	14.1	1.2	35.8	11.3	1.5	1.9	22.5	5.3	3.5	12.8	16.8	44.9	48.0	24.8	7.9	31.5	10.3	28.8	22.9	12.1	23.3	24.7	19.5	4.0	16.1	16.2	16.9	13.4	22.1	6.9	20.6	21.0	18.3	9.5	24.1	19.1	17.8	28.9	12.9	20.9	30.6	9.0	26.4	24.1	2.2	0.8	1.0	0.6	1.9	0.4	1.4	0.6	0.6	1.2	1.4	0.3	0.5	0.1	2.1	2.3	0.4	0.7	0.6	0.6	0.9	1.7	0.8	0.5	0.4	1.0	0.6	0.8	0.7	0.9	1.5	1.2	0.0	3.3	4.2	4.0	1.8	2.7	2.6	1.2	4.1	1.7	1.8	0.5	0.0	1.5	0.0	6.2	9.1	1.6	1.9	0.0	2.7	8.7	0.9	2.1	2.2	0.0	3.4	9.9	3.4	9.1	2.5	2.6	1.2	4.5	9.8	2.9	3.8	6.2	1.7	9.6	1.2	6.1	3.5	2.1	4.1	2.1	3.0	3.6	30.0	1.3	2.4	0.0	13.0	13.2	3.0	0.3	3.8	5.5	1.0	0.8	0.7	2.0	6.6	6.6	1.4	2.6	37.1	20.3	2.8	1.0	3.8	3.3	2.2	2.6	2.4
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188417	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.7	0.9	0.8	3.3	0.8	15.3	1.1	0.7	1.0	0.6	0.7	3.5	2.0	0.6	0.9	2.4	0.2	0.3	0.4	0.8	2.0	0.7	0.8	0.3	4.4	1.1	1.9	2.2	0.7	0.8	0.8	2.6	1.7	0.6	3.9	2.0	0.8	0.6	0.4	0.6	1.8	1.1	0.8	2.0	0.9	13.3	2.0	8.8	1.8	0.3	5.6	0.9	0.9	0.7	22.2	10.7	50.0	27.2	1.7	3.2	34.2	29.9	11.3	36.7	29.6	46.8	11.2	64.9	11.4	8.0	23.4	16.3	86.6	20.6	38.6	21.4	45.1	83.8	19.0	23.1	1.7	59.4	23.4	1.7	3.1	45.8	19.6	4.6	14.1	47.8	67.6	33.6	20.1	11.8	74.8	46.6	73.4	20.2	24.2	33.2	32.9	35.1	9.5	20.7	23.5	28.8	18.6	21.6	9.5	31.7	11.3	41.9	7.2	18.0	27.7	20.3	41.4	16.7	54.2	101.5	13.5	65.2	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.0	0.8	2.0	1.1	1.9	1.7	0.8	2.0	0.7	0.3	0.0	0.0	1.0	1.1	0.4	0.4	0.8	1.8	0.5	1.2	1.0	111.2	0.0	0.1	0.0	2.1	4.2	0.2	2.4	0.0	0.4	18.3	0.5	0.9	2.7	1.2	8.0	0.2	0.9	7.4	1.5	1.5	1.3	0.0	4.6	1.4	0.3	3.1	0.0	0.5	2.0	0.0	0.6	0.9	31.8	1.5	0.5	0.0	0.0	0.1	1.1	0.0	0.5	0.0	1.1	0.8	1.9	13.0	0.7	0.4	0.4	0.2	0.4	0.0	0.1	2.2	14.5	16.3	4.3	0.0	0.3	0.6	2.4	4.1	0.5
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479457-19520612	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;lymphoid tissue: 20.4;testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Erythroid cells: 29.7;Spermatocytes: 72.3;Spermatogonia: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"K-562: 370.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.5	0.5	0.7	6.2	0.5	25.4	1.5	0.2	0.2	1.1	0.4	4.6	3.5	0.9	0.3	5.3	0.4	0.5	0.3	0.2	0.4	0.3	1.2	0.9	11.3	0.5	0.4	0.2	0.2	0.2	0.1	3.2	0.5	0.4	6.0	0.1	0.9	0.2	0.1	3.3	3.1	1.8	0.2	2.8	2.6	23.4	1.1	20.4	0.3	0.0	11.8	1.9	1.7	0.3	57.4	42.2	56.4	42.9	2.0	5.6	24.4	65.4	31.6	75.5	75.5	35.8	30.5	62.2	23.2	21.0	28.9	51.9	58.2	45.9	59.5	72.3	96.3	82.8	50.1	41.3	3.1	125.0	43.7	1.3	2.4	57.9	26.0	7.0	38.8	63.0	370.6	73.3	44.8	77.2	98.1	56.5	16.7	106.2	34.4	77.1	95.5	26.5	16.9	49.3	72.1	37.0	38.1	40.0	12.0	21.7	26.2	51.0	15.0	60.0	91.6	46.0	62.8	24.6	46.8	67.5	30.1	58.9	82.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.2	0.1	0.5	0.5	0.1	0.3	0.9	0.6	0.7	0.5	0.2	0.2	0.2	0.4	0.5	0.4	0.5	0.2	1.1	0.3	0.2	0.0	0.0	0.0	1.9	2.7	1.7	3.7	0.0	0.0	0.7	0.8	0.4	0.0	0.5	0.0	0.0	11.9	1.4	1.9	0.0	0.8	120.5	0.9	0.7	1.2	0.0	29.7	0.1	0.0	19.8	2.3	1.5	1.0	0.0	5.5	3.6	0.0	7.2	0.0	0.1	1.2	4.1	0.6	1.0	14.4	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.7	12.6	0.2	0.4	0.0	0.3	0.0	6.6	1.5	13.9	72.3	50.7	3.3	1.8	4.9	1.2	0.8	5.1	2.5
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803789-88809258	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 38.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 149.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA017224: AB_1846468"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.7	0.8	0.8	3.8	1.2	38.5	0.7	2.5	1.3	1.7	0.0	3.3	4.1	0.5	0.2	6.7	0.5	0.2	0.5	0.8	2.3	0.7	1.0	1.3	4.8	2.2	1.1	0.4	0.6	1.3	2.1	2.8	1.9	0.7	1.6	0.4	1.1	0.2	0.1	3.6	3.9	0.6	0.7	3.1	2.4	3.5	1.1	8.7	0.6	0.0	3.3	0.5	2.3	1.0	33.6	34.5	16.5	25.3	0.7	3.4	64.2	24.1	6.6	19.4	12.0	79.3	33.8	51.4	24.2	5.5	12.7	46.0	21.6	17.7	6.2	18.2	92.1	51.8	28.8	59.9	0.3	28.8	21.5	1.8	1.4	19.8	4.4	1.6	5.9	60.9	80.8	18.4	7.6	90.6	109.3	149.4	41.8	12.2	31.6	120.3	22.9	42.4	4.3	23.8	36.6	26.2	44.4	13.1	16.9	7.4	39.0	55.9	5.9	24.6	42.6	37.2	35.4	61.4	55.7	73.6	19.3	71.9	31.6	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.7	0.4	0.1	0.1	0.7	0.2	0.8	1.2	2.5	1.3	0.8	2.3	2.2	1.1	1.9	0.7	1.1	1.0	0.4	0.0	1.1	0.7	4.9	11.2	4.3	1.4	7.4	0.7	5.4	7.5	2.2	1.5	1.7	1.8	0.0	51.4	2.2	12.7	1.9	1.1	0.4	1.4	1.4	2.2	2.4	71.3	0.2	0.0	92.0	5.2	9.2	2.2	0.0	29.0	0.4	1.0	19.5	0.0	0.8	16.1	4.1	5.6	5.5	1.2	0.3	2.8	1.8	0.0	1.9	1.5	4.1	0.0	0.6	0.6	2.3	0.4	23.1	2.2	2.0	1.6	2.1	1.9	0.0	2.1	3.4	6.6	37.1	10.8	7.1	24.8	5.4	5.7	30.1	4.4
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189574-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.8;testis: 29.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 74.5;Spermatocytes: 222.7;Spermatogonia: 222.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.2	2.0	1.4	7.5	1.7	33.8	7.7	1.7	2.0	3.9	1.0	7.4	6.5	4.5	2.1	7.5	4.0	1.8	4.0	1.5	1.6	1.6	3.6	2.8	17.7	1.6	1.5	3.9	1.5	2.0	1.4	5.2	1.6	3.3	8.1	2.5	2.9	2.3	4.0	9.2	5.9	3.7	1.4	5.2	3.7	29.7	1.6	18.5	2.5	4.0	18.8	3.8	4.4	2.2	64.6	19.4	88.6	70.2	5.8	18.3	48.0	31.2	32.6	66.9	71.8	26.5	79.6	138.9	36.6	18.1	39.1	47.0	59.0	70.4	85.1	42.7	41.4	32.7	32.5	26.4	2.0	47.1	32.1	7.1	14.6	43.6	47.7	18.9	23.2	73.7	58.7	53.3	52.2	35.6	152.4	67.3	78.1	20.7	17.0	93.2	118.2	108.2	21.1	22.9	61.6	81.9	34.6	22.8	27.5	47.7	31.9	31.4	11.4	33.4	56.1	44.5	78.7	65.5	106.3	111.8	51.1	94.2	64.7	1.0	2.0	3.0	4.7	3.5	7.7	13.3	7.9	6.0	3.1	14.1	9.9	8.6	0.4	8.6	4.2	6.7	9.7	4.8	1.4	1.7	1.7	2.0	1.5	1.6	1.6	1.5	1.6	1.4	1.6	2.2	4.8	0.0	2.6	1.0	18.3	36.7	17.7	17.4	9.6	3.4	10.8	11.7	3.3	4.3	7.1	0.0	0.0	37.4	9.2	5.1	0.0	12.3	26.5	5.5	5.1	6.9	1.2	74.5	1.3	9.1	49.0	7.4	2.6	4.8	5.1	22.4	4.6	1.1	17.0	0.0	1.1	9.5	12.2	7.5	18.2	22.5	3.7	6.3	8.8	1.0	4.3	7.3	6.2	1.0	0.9	7.0	2.5	4.9	14.4	6.9	1.4	3.4	10.8	3.5	19.7	6.4	9.3	222.7	222.8	12.1	19.2	10.0	12.0	6.9	15.9	15.2
CENPK	"CENP-K, FKSG14, SOLT"	ENSG00000123219	"Centromere protein K"	Q9BS16	5	65517766-65563168	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.6;lymphoid tissue: 22.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 50.9;Extravillous trophoblasts: 50.6;Spermatocytes: 101.3;Spermatogonia: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"				"unprognostic (4.04e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.69e-4)"	"unprognostic (3.22e-3)"	"unprognostic (9.59e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.98e-2)"	"unprognostic (6.33e-15)"	"unprognostic (2.22e-1)"	"unprognostic (2.97e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.11e-1)"	1.1	0.9	0.6	10.6	0.7	24.6	3.8	1.0	0.8	1.2	1.6	9.0	8.3	1.9	0.9	5.6	2.3	1.9	0.5	0.5	0.6	0.8	1.9	2.0	14.6	1.0	0.7	0.8	0.6	1.0	0.3	5.5	1.1	1.3	11.9	0.7	1.4	0.7	0.2	8.6	8.6	3.4	0.7	4.5	5.5	13.4	1.0	22.2	1.2	0.5	12.4	2.6	2.4	1.4	65.3	41.4	85.6	29.5	4.4	12.0	40.8	69.8	26.5	58.7	73.6	35.1	97.2	39.3	25.2	23.6	59.5	39.7	33.3	35.4	92.7	45.2	28.5	42.1	50.7	33.8	1.7	50.1	36.8	5.6	5.0	56.9	27.3	10.6	56.4	42.2	31.8	57.7	59.1	21.5	85.4	56.2	41.1	18.5	17.1	52.5	81.9	43.8	38.8	34.4	35.8	28.9	53.7	22.1	28.7	31.8	40.0	36.9	20.3	44.9	46.5	31.1	82.2	30.0	51.9	83.0	41.9	74.0	49.9	3.7	0.7	2.3	9.9	1.0	14.8	4.0	21.1	12.5	1.7	7.0	28.5	20.2	1.7	10.2	1.1	1.6	23.2	10.0	0.6	0.7	1.0	0.8	0.5	0.6	1.0	0.7	1.1	0.7	1.0	1.4	2.7	0.0	3.4	0.3	11.7	23.6	8.5	14.0	4.6	1.6	6.0	7.9	0.9	0.0	8.1	0.0	0.0	28.8	18.7	5.8	1.9	3.1	27.6	25.5	4.5	5.7	0.0	50.9	3.1	1.0	50.6	6.3	9.2	7.2	2.5	22.7	3.9	1.1	22.4	0.0	2.3	14.7	8.2	1.9	12.0	17.4	1.5	5.7	1.8	11.2	1.8	0.6	7.2	2.0	1.4	2.3	2.1	1.5	14.1	2.2	1.1	0.3	7.1	1.1	0.0	2.3	9.1	101.3	75.1	17.0	8.1	6.7	20.7	3.9	15.8	11.4
CENPN	"BM039, C16orf60, FLJ13607, FLJ22660"	ENSG00000166451	"Centromere protein N"	Q96H22	16	81006552-81033114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 37.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 64.2;Extravillous trophoblasts: 91.1;Spermatocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052870			Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052870: AB_2681978"	"unprognostic (1.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.99e-2)"	5.1	5.0	3.2	7.9	4.0	37.4	3.6	3.1	4.9	2.8	2.1	8.0	7.8	2.3	3.1	7.5	1.6	3.1	5.7	3.3	3.1	5.4	9.0	3.3	11.0	3.8	4.0	1.5	5.2	8.6	1.6	8.9	3.4	18.7	7.6	1.4	2.5	2.7	4.5	3.8	6.4	6.4	2.7	4.3	5.2	11.2	3.9	18.1	2.8	2.6	12.0	6.0	2.8	5.8	86.2	81.0	64.9	58.4	16.9	15.1	82.6	97.5	59.3	137.0	59.6	150.8	64.6	48.1	52.4	48.9	62.7	69.9	53.1	61.5	172.9	29.3	47.9	43.0	63.3	100.9	9.6	64.6	80.4	14.0	6.6	123.3	40.8	18.0	62.6	59.1	83.6	65.9	66.9	160.1	78.0	79.6	69.7	37.2	45.4	90.9	64.5	51.3	22.5	58.6	43.2	38.9	140.3	31.8	40.1	38.9	76.2	34.0	38.5	97.7	101.1	66.8	96.8	46.4	112.1	186.8	45.8	43.7	85.8	0.9	1.4	2.4	2.1	2.8	2.0	1.6	2.7	1.5	6.6	5.9	1.3	1.5	1.7	3.6	3.1	2.2	7.9	2.0	3.2	4.0	3.1	4.9	3.3	3.1	3.8	4.0	3.4	2.7	3.9	5.8	2.8	0.0	4.8	1.0	10.2	24.0	15.7	9.6	14.8	1.0	6.0	7.0	4.8	5.7	5.8	3.7	0.0	47.1	10.0	7.4	0.0	5.7	41.8	4.5	3.8	5.8	1.2	64.2	1.9	6.5	91.1	9.7	11.7	6.4	6.3	13.2	6.8	6.3	27.2	0.0	1.1	12.8	12.2	9.7	20.2	40.9	2.8	10.4	7.2	1.0	4.4	0.8	0.0	0.5	6.1	5.1	4.0	3.4	34.7	13.6	5.1	8.8	1.8	0.4	0.0	7.1	10.0	52.3	39.1	32.7	16.3	27.2	10.9	6.3	22.0	16.6
CENPW	"C6orf173, CUG2"	ENSG00000203760	"Centromere protein W"	Q5EE01	6	126340115-126348875	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.6;testis: 39.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 329.7;Extravillous trophoblasts: 155.9;Spermatocytes: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA067285			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067285: AB_2685818"	"unprognostic (3.51e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.26e-3)"	"unprognostic (9.61e-3)"	"unprognostic (3.78e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.11e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-1)"	8.2	4.3	2.5	12.8	2.3	50.6	6.6	2.0	3.5	14.4	1.4	15.0	8.3	21.6	7.0	23.1	9.2	5.4	1.7	4.2	2.0	3.4	3.6	4.9	15.5	1.9	2.0	4.1	2.1	2.8	2.5	7.8	1.7	6.3	17.5	1.6	8.5	4.4	3.0	8.3	10.8	16.1	1.9	6.8	6.3	39.5	2.0	27.4	2.5	1.9	20.5	6.6	10.9	2.4	73.4	49.0	94.7	82.9	10.3	10.4	81.2	60.0	43.6	81.3	98.3	148.0	50.1	86.8	48.8	38.3	128.7	88.0	78.0	94.3	114.6	94.0	140.2	84.7	141.4	166.3	3.4	123.8	59.1	6.4	10.0	69.1	51.2	23.1	88.3	116.8	144.1	56.5	69.6	119.3	103.1	204.4	60.5	64.0	74.3	107.7	63.2	62.6	38.0	33.0	99.1	44.0	50.8	46.5	67.4	76.9	43.7	119.5	48.0	76.6	78.3	104.6	163.7	36.9	72.7	156.8	45.9	147.0	92.8	3.2	16.9	2.3	2.0	20.3	0.6	6.0	4.4	4.3	15.9	3.5	3.4	2.7	2.9	6.9	14.1	18.9	12.0	5.9	2.5	2.3	2.0	3.5	4.2	2.0	1.9	2.0	1.7	1.9	2.0	2.4	2.5	0.0	2.6	1.0	18.6	38.0	13.4	54.3	6.2	1.3	10.3	18.7	0.3	11.5	29.4	1.8	2.1	52.2	6.1	23.5	5.9	16.6	329.7	18.0	26.5	11.0	7.8	75.1	23.7	17.9	155.9	25.1	17.3	12.7	13.4	31.4	10.8	6.0	63.6	3.3	22.0	27.1	42.7	15.6	40.1	39.3	19.3	19.3	8.8	1.0	12.6	3.1	3.1	1.0	2.4	17.2	10.6	9.1	38.6	24.7	18.1	1.6	7.0	1.4	0.0	6.4	18.1	148.3	83.8	60.9	29.0	21.2	8.6	11.4	51.7	35.8
CIP2A	KIAA1524	ENSG00000163507	"Cellular inhibitor of PP2A"	Q8TCG1	3	108549864-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.5;lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 8.0;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 12.9;Granulosa cells: 25.3;Hofbauer cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	1.1	1.1	0.3	3.4	0.6	7.5	1.4	0.9	0.8	0.9	0.1	1.9	1.2	1.8	0.6	1.7	0.9	1.2	0.7	0.6	0.5	1.0	0.7	1.4	6.7	0.2	0.9	1.9	0.4	0.6	0.7	2.1	0.2	1.8	2.7	2.6	0.6	0.8	0.6	1.2	1.7	1.5	0.0	2.3	1.2	5.7	0.1	6.9	1.2	0.7	5.2	2.0	0.9	0.4	42.2	12.2	33.9	21.8	1.4	3.2	13.8	31.1	14.7	36.2	41.9	15.0	18.5	27.6	10.4	11.4	27.7	20.9	11.7	11.0	65.8	8.8	11.3	33.9	17.4	11.3	0.5	21.8	23.2	1.4	2.3	28.4	11.5	5.9	16.3	12.7	21.1	44.5	36.1	8.7	26.7	19.2	35.0	15.8	20.8	30.1	31.2	15.3	11.0	11.5	16.4	21.6	22.9	9.0	12.7	19.7	15.3	15.6	12.2	37.0	41.7	11.3	38.3	10.2	12.1	46.1	16.4	23.2	38.6	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.6	0.9	0.8	0.6	0.5	0.2	0.9	0.2	0.0	0.1	0.4	1.2	9.6	1.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	2.5	3.7	0.0	8.0	1.8	0.0	1.9	2.8	0.0	2.5	2.8	2.6	0.0	0.0	0.0	7.3	12.9	3.0	0.0	2.7	3.8	25.3	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	2.4	1.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.4	1.7	5.4	0.0	0.0
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685791-119877320	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 72.8;Excitatory neurons: 147.0;Inhibitory neurons: 139.8;Oligodendrocyte precursor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752"	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	0.7	2.2	13.5	1.6	26.2	6.3	0.6	0.0	19.9	0.9	0.0	2.1	1.2	0.4	0.0	2.5	0.5	0.5	0.6	15.2	5.4	2.5	0.3	1.8	1.5	0.2	5.0	0.3	0.2	0.1	1.6	1.4	0.4	0.5	2.5	3.4	0.8	0.2	0.5	1.6	1.9	0.9	0.9	3.0	2.2	4.8	14.2	6.8	0.6	0.3	2.3	0.5	1.3	6.6	26.2	20.6	21.7	15.3	2.4	6.3	10.4	22.0	19.1	21.8	16.6	14.5	10.3	18.4	10.0	14.2	9.3	14.6	14.4	9.5	32.1	13.6	7.5	25.7	13.2	7.1	0.3	12.7	20.6	0.9	1.2	23.7	14.8	7.3	15.5	19.9	14.5	15.2	19.5	12.2	22.4	14.0	10.4	8.7	12.5	19.3	39.8	6.3	5.0	11.1	15.5	8.4	31.9	6.5	16.0	9.6	23.2	10.6	11.5	21.9	21.4	17.2	22.7	9.9	12.6	14.2	16.8	12.5	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.5	26.2	0.0	19.9	15.2	5.4	0.2	5.0	0.4	0.9	14.2	6.6	4.1	6.4	13.0	8.5	1.2	3.3	0.7	1.0	0.6	8.2	1.8	1.5	1.8	0.0	5.6	9.2	87.6	3.5	0.6	1.1	0.0	0.2	72.8	2.4	2.1	2.7	1.8	12.8	147.0	0.8	4.8	2.2	3.1	3.6	1.3	10.5	1.1	0.7	3.6	0.0	139.8	4.4	6.1	3.7	0.8	44.1	1.2	2.0	3.6	7.5	0.0	15.4	1.0	82.4	18.7	0.2	0.1	1.2	4.1	0.4	0.8	7.5	1.7	15.2	0.0	0.6	3.3	33.2	4.2	7.7	1.3	1.0	2.2	4.3	4.4	1.0
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 67.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 122.9;Granulosa cells: 88.6;Spermatocytes: 151.7;Spermatogonia: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA008410, HPA027821"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centrosome"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Centrosome	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	6.0	6.4	3.7	10.0	3.8	67.8	5.7	10.8	5.3	3.2	1.3	8.9	12.1	5.1	4.4	10.4	3.5	4.1	6.0	3.2	4.1	5.1	4.0	5.3	19.4	4.8	3.8	3.2	1.5	4.3	4.5	10.6	5.2	5.6	9.5	7.7	4.6	4.2	2.9	13.9	9.5	8.5	3.3	9.4	5.4	32.5	3.7	33.7	6.3	3.4	20.2	7.2	5.0	3.1	77.6	40.0	155.7	76.4	19.7	19.5	39.6	124.7	70.7	137.4	87.2	59.7	92.3	142.5	19.3	89.2	65.7	86.2	107.6	61.7	188.8	103.0	90.4	129.8	42.6	41.4	8.6	129.7	50.4	14.5	24.6	64.5	83.3	41.2	84.0	62.0	55.3	58.1	152.8	36.0	91.2	64.8	92.2	116.6	42.4	86.2	88.6	62.6	42.1	40.9	47.6	62.4	68.9	49.0	37.1	78.7	54.4	61.7	56.7	38.7	60.9	62.0	124.1	33.4	56.3	173.9	27.3	67.3	105.7	86.0	14.1	22.0	10.3	21.0	9.3	25.3	15.7	12.8	15.8	33.0	12.0	10.4	4.3	5.8	28.7	32.8	33.6	10.0	3.7	3.8	10.8	5.3	3.2	4.1	4.8	3.8	5.2	3.3	3.7	3.1	6.7	6.4	2.8	5.2	41.2	15.0	4.5	32.8	22.2	13.1	11.2	13.2	10.8	2.8	11.4	1.8	6.2	44.3	30.9	7.5	9.8	4.9	41.3	19.4	16.1	12.7	7.2	122.9	10.3	6.0	38.1	12.1	10.7	10.1	16.5	88.6	17.5	5.5	31.8	1.7	12.4	13.6	20.3	24.5	13.7	51.7	7.5	18.5	0.0	6.5	22.9	12.9	5.2	3.5	2.0	2.6	4.6	17.0	30.8	3.7	6.3	9.4	3.7	6.6	6.6	7.6	12.1	151.7	87.5	41.3	15.3	10.0	27.1	29.6	17.9	3.9
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 119.7;Spermatocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Centrosome"		NA	Yes		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centrosome"	"Nucleoli, Nucleoli rim"	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	12.8	30.7	15.9	15.1	19.5	25.9	14.9	30.8	24.3	11.7	5.2	18.5	12.6	15.7	12.2	13.0	11.5	12.2	21.3	21.4	18.0	11.5	45.5	10.4	18.4	21.0	17.4	27.8	9.0	21.2	12.5	17.3	22.9	15.9	17.2	57.0	9.1	13.2	37.8	13.7	12.3	19.3	17.5	11.9	16.1	33.0	20.2	36.4	9.6	28.8	18.5	13.5	10.8	24.6	104.7	95.8	212.6	90.8	48.7	73.0	48.3	117.1	69.4	107.8	114.6	76.8	33.3	104.5	41.0	76.0	117.0	116.2	144.0	62.7	134.3	102.0	107.6	176.6	80.2	78.4	35.0	139.6	76.7	37.0	34.0	60.3	125.6	56.1	79.3	97.9	129.5	103.8	89.2	71.2	127.9	39.2	114.7	78.8	73.0	131.2	210.0	98.3	34.7	63.3	96.8	83.9	149.8	56.9	57.3	88.9	103.9	39.1	64.0	106.2	92.9	180.8	176.2	59.2	137.3	158.6	66.5	64.9	105.9	4.6	4.2	4.6	6.1	6.2	5.9	6.5	4.5	6.9	6.1	6.2	5.4	5.8	0.7	8.6	6.2	3.9	5.6	3.1	15.9	19.5	30.8	24.3	21.4	18.0	21.0	17.4	22.9	17.5	20.2	24.6	13.4	25.6	23.6	32.3	17.4	8.5	11.0	17.9	16.5	19.3	11.6	12.3	65.2	12.8	18.8	9.2	37.5	19.4	11.2	13.3	9.8	12.2	119.7	19.7	21.0	16.5	12.1	32.6	61.9	7.8	15.0	27.8	29.0	18.8	37.9	55.5	11.7	8.1	18.7	13.5	63.1	16.9	16.2	17.6	5.6	50.7	19.6	19.6	7.2	30.9	16.5	16.2	16.5	32.6	51.7	13.7	15.2	29.0	26.4	14.2	9.1	9.3	30.7	25.6	19.7	18.0	21.4	107.4	59.3	24.3	11.6	11.5	16.1	83.3	19.8	9.7
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424171-86456553	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 117.5;skin 1: 88.7;vagina: 53.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 47.4;Basal respiratory cells: 57.5;Basal squamous epithelial cells: 39.9;Club cells: 37.1;Early spermatids: 30.2;Squamous epithelial cells: 167.1;Suprabasal keratinocytes: 54.8;Urothelial cells: 52.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 146.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 210.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		96000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.8	0.1	0.2	0.1	0.6	0.0	4.6	0.4	0.5	22.8	0.1	0.6	0.2	0.0	0.5	117.5	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.7	0.4	2.4	0.7	0.0	13.2	0.2	0.2	88.7	0.8	0.0	0.4	0.0	0.1	0.6	0.3	1.0	0.0	0.0	26.0	21.2	53.1	1.0	0.0	0.0	0.0	0.0	0.6	3.0	38.9	1.7	2.7	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	0.0	33.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	210.8	1.0	10.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.9	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.5	0.2	0.3	0.4	0.3	0.4	0.4	0.3	1.0	0.0	0.0	0.0	0.7	0.0	47.4	13.1	57.5	39.9	0.0	7.7	2.8	0.4	0.0	37.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.3	4.1	0.0	3.1	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	2.5	2.1	0.3	0.0	8.0	0.0	0.0	0.0	0.6	0.2	0.0	167.1	54.8	0.1	0.5	0.0	0.1	52.9
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424619-69466264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 318.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"		NA	NA		99000	"Cluster 44: Non-specific - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	60.2	318.0	52.3	51.4	53.9	20.9	50.4	46.0	69.9	45.8	43.6	92.6	69.5	49.3	72.8	59.3	58.2	45.4	58.0	56.9	51.2	71.9	83.8	54.1	68.8	50.7	48.1	44.0	40.1	77.7	28.6	73.8	50.6	47.6	116.0	49.4	36.3	48.3	65.8	45.8	67.8	61.6	44.7	49.6	49.3	38.6	52.3	74.3	54.1	78.2	76.9	80.4	38.2	48.4	186.2	576.4	232.9	144.9	105.1	139.3	99.5	162.3	224.1	266.0	249.2	406.1	221.3	168.0	159.3	157.9	216.0	214.5	224.4	235.0	300.0	90.2	85.5	81.2	97.1	479.1	154.7	169.1	172.4	120.9	116.3	315.9	149.6	111.8	254.7	190.5	133.6	78.4	165.2	241.2	278.9	204.1	173.5	171.4	78.4	260.0	128.7	184.3	359.3	208.7	135.7	69.7	431.6	82.0	142.2	119.0	159.0	133.2	115.9	152.2	124.5	102.2	145.5	94.7	227.0	516.6	157.0	138.0	180.0	121.1	57.6	71.5	103.8	80.0	85.0	68.8	76.9	81.8	69.8	63.1	62.8	75.5	17.1	96.4	59.7	124.2	134.6	105.6	52.3	53.9	46.0	69.9	56.9	51.2	50.7	48.1	50.6	44.7	52.3	48.4	36.2	44.8	46.8	44.7	47.2	49.8	49.2	84.0	66.0	22.8	28.6	26.0	25.0	30.0	51.4	62.5	6.2	159.8	66.7	112.7	78.2	66.2	18.8	56.4	33.3	61.7	23.4	38.7	40.9	70.4	94.1	38.4	27.5	87.7	60.2	36.6	43.9	54.9	64.8	30.3	30.4	76.6	83.4	30.1	57.5	22.7	44.4	33.4	62.2	24.4	55.8	63.0	96.8	23.6	39.4	70.5	78.8	44.4	28.1	34.9	75.9	62.9	49.5	31.6	46.0	22.2	36.5	48.1	46.6	44.9	42.3	59.8	54.1	84.8	61.6	50.4
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163928	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;testis: 18.9"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 414.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032151			Supported	"Plasma membrane,Microtubules"		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Microtubules"		"HPA032151: AB_2674181"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (9.04e-4)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	0.4	0.1	0.1	1.7	0.2	7.1	0.8	0.3	0.3	0.3	0.2	1.9	1.9	0.6	0.0	2.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	1.2	2.4	0.2	0.3	0.1	0.2	0.1	0.0	3.5	0.2	0.1	2.1	0.0	0.5	0.0	0.0	1.3	1.6	2.6	0.1	0.5	1.6	18.9	0.3	5.4	0.1	0.0	2.4	0.6	0.7	0.2	47.7	15.6	15.8	9.1	2.7	7.1	26.9	65.0	28.7	64.2	55.6	41.7	31.4	15.9	5.2	33.4	16.7	31.7	26.0	25.5	96.9	18.0	17.9	22.7	37.6	9.5	4.1	31.2	17.4	2.8	0.6	39.2	26.3	16.3	29.2	14.0	17.8	21.9	61.8	6.9	28.0	10.2	14.7	22.5	8.9	18.8	38.9	12.9	19.9	9.6	8.3	14.3	33.2	22.8	9.5	33.8	16.7	16.8	29.3	40.5	25.9	13.7	54.5	14.7	17.1	24.4	10.9	15.2	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.2	0.3	0.2	0.1	0.3	0.2	0.6	54.5	3.4	39.8	1.9	3.7	0.8	2.1	2.8	0.0	3.9	1.5	1.0	2.8	1.8	0.0	0.0	21.1	1.1	3.8	5.9	1.3	414.4	2.5	3.5	2.1	0.0	26.7	5.6	4.0	30.7	5.8	9.7	9.3	0.0	78.8	1.8	0.4	6.1	0.0	3.3	2.6	2.0	1.0	1.2	56.0	0.6	1.5	0.0	5.6	0.1	3.5	2.1	19.1	1.8	1.5	0.2	0.0	18.9	0.4	1.1	5.4	0.2	0.0	0.0	0.0	7.9	39.2	17.8	11.6	1.1	7.3	2.2	2.8	5.6	1.5
E2F7		ENSG00000165891	"E2F transcription factor 7"	Q96AV8	12	77021248-77065569	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 8.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 46.9;Endometrial ciliated cells: 17.2;Late spermatids: 70.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"midbrain: 5.8;pons: 6.4;thalamus: 11.3"	HPA064866			Supported	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA064866: AB_2685374"	"unprognostic (1.21e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.67e-5)"	"unprognostic (1.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-1)"	0.2	0.1	0.2	1.1	0.2	5.0	0.2	0.0	0.3	0.3	0.3	0.9	0.7	0.2	0.0	1.4	0.6	0.7	0.2	0.2	0.2	0.1	0.2	0.3	1.5	0.7	0.8	0.1	0.2	0.1	0.5	1.0	0.4	0.2	1.5	0.2	0.2	0.1	0.0	1.1	0.8	0.3	0.6	0.3	0.6	2.9	0.2	8.3	0.1	0.1	1.6	0.6	0.5	0.2	20.1	9.4	25.7	10.1	0.8	2.5	31.1	27.6	29.8	14.2	17.0	12.8	6.6	11.2	5.4	5.5	29.5	15.1	15.5	29.8	27.1	4.4	10.4	9.8	27.3	7.3	5.9	8.5	8.8	0.8	7.7	37.4	22.9	8.3	14.2	19.0	10.4	8.9	29.5	10.1	31.9	0.1	18.1	6.7	21.9	23.0	22.2	6.2	3.5	16.8	16.3	10.7	22.9	7.9	6.5	10.9	12.6	8.7	39.3	53.5	26.8	23.0	36.7	9.5	5.8	7.1	19.3	3.8	34.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.2	0.2	0.0	0.3	0.2	0.2	0.7	0.8	0.4	0.6	0.2	0.2	0.1	0.0	0.5	2.3	0.5	0.3	1.0	1.4	4.6	0.0	0.6	0.9	2.1	0.0	2.2	0.0	0.0	1.8	0.4	1.5	0.0	0.3	46.9	17.2	0.8	1.5	0.0	7.4	0.4	1.1	3.1	0.8	6.1	3.1	4.5	6.3	0.0	0.0	0.9	0.0	0.2	1.2	2.0	0.3	1.2	70.2	0.3	1.3	0.0	3.7	0.0	1.6	0.0	0.5	0.0	12.0	0.1	0.7	6.9	1.7	0.0	0.0	3.1	0.1	0.0	0.0	1.2	1.2	2.1	6.3	0.6	0.3	0.8	0.4	2.1	4.3
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 11.8;skeletal muscle: 12.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	0.3	0.1	0.0	2.8	0.0	14.2	0.5	0.1	0.1	1.0	0.0	4.0	3.8	0.4	0.0	4.9	0.9	0.4	2.1	0.0	0.0	0.1	0.3	0.3	7.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	5.1	0.0	0.9	0.2	12.6	3.0	3.0	0.6	0.0	1.3	5.6	1.7	0.0	11.8	0.1	0.4	7.3	1.8	1.3	0.1	23.3	7.2	7.1	9.8	0.4	1.1	31.7	13.0	3.7	15.3	16.4	25.4	7.8	23.5	5.5	4.3	9.0	20.2	17.2	1.6	13.5	15.9	14.9	8.0	4.1	7.1	0.0	12.7	19.2	0.3	0.1	3.1	1.0	0.9	21.0	17.2	17.6	22.1	6.3	11.6	25.8	16.6	6.9	26.3	10.1	26.9	12.8	16.0	6.6	16.8	6.0	7.0	5.5	11.3	1.3	4.0	7.7	13.7	4.2	7.3	9.0	18.3	11.8	7.7	16.2	30.6	9.0	24.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.1	1.3	0.0	0.0	0.3	0.1	3.8	0.0	0.5	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.4	3.3	0.8	0.8	1.2	34.1	0.1	0.0	1.7	1.0	10.2	3.3	0.0	3.1	0.0	0.0	2.4	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.2	0.0	9.7	0.1	0.4	0.2	5.6	0.0	0.0	1.5	0.9	4.0	3.1	10.0	0.3	0.3	2.2	0.5	6.3	0.9
EME1	"FLJ31364, MMS4L, SLX2A"	ENSG00000154920	"Essential meiotic structure-specific endonuclease 1"	Q96AY2	17	50373220-50381483	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.4;epididymis: 6.3;testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.6;Extravillous trophoblasts: 4.8;Granulosa cells: 4.5;Spermatocytes: 13.2;Spermatogonia: 9.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	33	"basophil: 18.6"	"Lineage enriched"	"Detected in single"	33	"granulocytes: 18.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016127, HPA052188"	Supported		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Cytosol"		"CAB016127: AB_2278026, HPA052188: "	"unprognostic (3.81e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.94e-5)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.83e-3)"	"unprognostic (0.00e+0)"	"unprognostic (9.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-1)"	0.5	0.3	0.2	1.7	0.3	4.4	0.6	0.1	0.4	0.5	0.0	0.9	0.8	0.4	6.3	1.1	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.4	2.3	0.3	0.2	0.5	0.2	0.1	0.1	1.4	0.3	0.2	1.3	0.4	0.5	0.1	0.2	1.1	0.7	0.6	0.1	0.9	0.5	5.7	0.3	3.3	0.2	0.0	2.6	0.4	0.5	0.4	13.9	20.0	26.2	13.7	1.2	2.6	18.8	14.2	5.4	19.3	17.7	31.7	11.0	11.0	18.3	5.7	12.0	10.7	24.5	11.3	27.3	21.7	19.3	26.3	23.3	14.8	0.1	10.9	8.4	0.5	0.8	22.3	9.2	2.6	4.5	31.2	16.3	25.6	11.6	15.2	25.0	13.9	15.1	14.2	13.6	25.5	50.7	15.4	4.3	5.6	10.1	20.2	8.7	4.8	8.1	20.9	16.8	12.3	3.1	24.8	14.9	16.6	19.7	16.0	17.4	10.5	7.8	12.2	15.6	18.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.3	0.1	0.4	0.1	0.1	0.3	0.2	0.3	0.1	0.3	0.4	0.1	0.0	1.1	0.3	0.8	0.1	0.3	0.5	0.6	1.5	0.5	0.3	0.4	0.0	0.7	0.0	0.0	4.6	0.5	0.6	0.0	0.3	0.5	0.8	0.7	0.4	0.0	3.8	0.1	0.0	4.8	0.8	2.0	0.5	0.0	4.5	0.0	0.3	2.2	0.0	0.1	0.9	0.0	0.0	1.4	0.6	0.6	0.8	0.0	0.0	1.0	0.5	1.0	0.0	0.3	0.1	0.0	0.0	2.5	0.1	0.1	0.0	0.9	0.3	0.0	0.6	1.0	13.2	9.1	1.5	0.1	1.1	0.5	0.6	1.3	0.2
ERMP1	"FLJ23309, FXNA, KIAA1815"	ENSG00000099219	"Endoplasmic reticulum metallopeptidase 1"	Q7Z2K6	9	5765076-5833117	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 50.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 73.5;Granulosa cells: 53.4;Oligodendrocytes: 88.8;Urothelial cells: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.8;RT4: 154.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055582	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA055582: "	"unprognostic (1.93e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.97e-1)"	"unprognostic (8.59e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.81e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (5.83e-10)"	"unprognostic (1.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	3.9	7.9	4.2	3.7	10.4	2.0	6.3	10.9	3.7	10.8	14.4	11.3	4.4	5.6	2.6	14.9	6.4	11.3	10.0	2.9	6.1	24.9	4.6	6.3	3.5	10.1	10.3	4.5	3.9	50.1	1.5	7.8	8.8	6.0	11.4	2.2	19.1	4.1	7.6	9.3	6.5	3.8	6.5	3.1	13.3	4.7	8.9	4.6	26.6	9.9	6.4	17.1	4.8	13.1	45.1	43.1	1.8	5.2	22.6	20.7	22.6	5.1	11.1	2.3	1.9	10.4	27.2	10.7	19.2	8.4	25.9	32.2	9.6	29.4	3.3	55.6	7.6	56.2	20.0	20.4	4.8	16.0	21.3	10.5	12.9	2.1	13.3	28.6	30.1	4.6	6.9	9.9	2.8	20.7	0.6	6.2	6.6	28.0	8.4	1.7	5.3	14.1	76.8	154.6	9.9	3.3	7.1	52.2	8.1	24.5	33.7	20.5	18.0	1.5	5.0	3.4	16.1	8.9	13.6	5.5	6.7	13.0	4.1	0.2	0.1	0.3	0.4	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.1	0.1	0.1	4.2	10.4	10.9	3.7	2.9	6.1	10.1	10.3	8.8	6.5	8.9	13.1	3.4	6.4	1.1	24.8	2.2	2.9	18.3	13.3	2.8	4.0	11.1	5.8	13.7	12.8	22.8	73.5	10.4	6.8	5.2	32.1	0.0	4.6	22.3	11.4	10.9	6.3	11.4	6.3	21.0	3.0	7.1	4.6	13.7	13.8	8.9	53.4	2.9	6.1	5.7	3.3	32.8	8.9	10.2	1.6	2.2	41.8	3.1	4.5	1.8	24.4	2.1	3.0	8.2	22.1	88.8	3.5	22.5	4.9	4.1	7.0	9.2	3.3	16.6	2.9	6.6	5.8	4.3	8.8	4.6	17.5	4.5	4.1	5.9	39.8	15.7	66.9
FANCA	"FA-H, FAA, FACA, FAH, FANCH"	ENSG00000187741	"FA complementation group A"	O15360	16	89737549-89816657	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.2;testis: 21.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.1;Spermatogonia: 38.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063236			Supported	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA063236: AB_2684966"	"unprognostic (5.99e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.45e-4)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.48e-4)"	"unprognostic (7.82e-10)"	"unprognostic (3.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.62e-1)"	1.4	1.9	1.7	6.7	1.9	20.2	1.9	2.4	3.3	2.1	1.5	5.5	5.2	1.2	0.8	6.6	2.0	1.2	1.6	1.8	1.2	2.9	6.1	3.4	12.5	1.4	1.1	1.4	1.9	1.4	1.9	4.1	1.5	1.7	6.2	1.0	2.1	0.6	0.7	5.2	5.6	2.1	1.1	6.7	3.6	21.6	1.5	8.1	1.7	0.6	13.5	2.2	2.7	1.9	23.2	34.8	40.8	35.7	2.6	5.2	31.2	28.2	15.3	46.5	19.5	30.6	37.3	56.2	12.9	9.8	15.5	34.7	27.7	21.1	48.8	13.4	46.5	16.6	49.1	63.4	1.7	17.1	17.5	1.7	2.2	37.8	12.0	6.6	14.9	28.0	40.9	16.9	24.6	53.6	34.6	73.7	26.5	31.5	21.3	61.4	32.8	10.3	11.8	21.5	36.3	19.7	41.9	12.3	5.4	23.3	22.4	30.4	11.1	37.0	38.9	20.9	30.0	15.1	19.0	56.3	17.5	37.8	36.1	2.5	7.4	9.9	4.2	8.5	3.0	7.0	2.4	3.7	6.2	4.6	0.6	2.6	9.4	8.2	9.2	0.4	9.2	4.2	1.7	1.9	2.4	3.3	1.8	1.2	1.4	1.1	1.5	1.1	1.5	1.9	1.5	0.0	1.1	0.7	9.6	3.4	1.6	2.6	0.0	8.1	3.0	2.0	2.9	0.0	3.5	16.5	10.4	16.0	12.3	5.1	1.9	2.0	5.9	2.8	3.5	2.1	1.8	20.8	10.0	1.6	9.9	3.3	9.2	3.4	2.5	19.0	5.3	4.7	8.8	3.3	5.7	8.1	2.0	4.1	3.1	4.1	1.5	6.8	0.0	1.0	3.0	1.1	21.6	3.0	1.7	1.9	1.7	0.0	21.1	1.3	6.6	10.4	6.4	7.7	0.0	2.7	3.5	44.1	38.5	3.8	1.8	25.3	9.3	6.8	11.4	2.6
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"FA complementation group I"	Q9NVI1	15	89243945-89317261	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;lymphoid tissue: 44.2;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.6;Spermatocytes: 69.5;Spermatogonia: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039972: AB_10673265, HPA040379: AB_2676951"	"unprognostic (6.88e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.59e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.71e-13)"	"unprognostic (2.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	3.2	2.1	1.6	13.0	1.3	31.4	6.0	3.8	2.5	3.3	0.0	10.5	6.0	4.7	1.1	8.1	3.4	3.0	1.7	1.7	0.7	1.7	2.9	3.4	23.9	1.2	0.9	3.8	3.0	3.0	0.6	11.3	1.7	3.6	12.4	5.4	2.8	2.0	0.8	8.0	7.3	6.9	0.6	6.0	6.7	32.6	1.3	44.2	2.0	0.8	26.6	5.4	3.7	1.7	108.2	122.4	127.8	86.1	10.8	16.0	78.5	101.4	58.3	123.6	150.5	96.8	95.4	198.8	53.4	33.8	79.3	143.9	196.8	69.0	116.2	127.8	123.5	197.2	176.7	45.8	1.7	146.0	96.3	8.6	6.8	87.1	44.4	17.6	51.7	120.2	139.2	142.3	83.5	61.5	150.9	49.6	101.1	70.3	44.5	130.6	187.1	84.6	28.5	196.8	93.9	80.8	105.2	73.3	46.7	85.7	81.2	64.8	35.4	103.2	103.8	94.9	155.8	93.3	209.5	151.9	38.5	125.7	104.7	23.4	2.3	3.0	4.7	3.0	2.8	3.5	4.7	6.5	2.2	3.6	3.3	5.6	3.1	5.1	4.3	4.1	11.8	3.1	1.6	1.3	3.8	2.5	1.7	0.7	1.2	0.9	1.7	0.6	1.3	1.7	2.6	3.2	1.5	3.6	3.8	4.2	2.6	4.0	0.6	2.4	2.9	2.7	3.9	0.0	3.3	1.8	0.0	17.0	3.9	4.2	0.0	2.0	7.9	5.0	3.7	3.0	1.2	48.6	7.0	2.9	18.3	3.9	5.6	4.5	2.5	14.9	6.8	0.8	8.1	1.7	5.8	5.9	0.0	3.0	3.8	7.9	3.4	4.8	1.8	1.9	3.3	11.6	1.0	9.0	6.9	2.5	1.2	1.5	13.9	2.0	1.3	1.0	6.3	1.9	6.6	3.6	4.0	69.5	60.2	9.2	2.4	12.4	8.1	2.5	9.1	2.8
GAB1	DFNB26	ENSG00000109458	"GRB2 associated binding protein 1"	Q13480	4	143336762-143474568	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 162.7;Microglial cells: 192.0;Oligodendrocyte precursor cells: 288.0;Oligodendrocytes: 1013.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034333, HPA066404"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli fibrillar center, Plasma membrane"	Cytosol	"CAB034333: AB_2107855, HPA066404: "	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	7.9	8.6	23.3	6.7	69.9	11.5	9.9	35.5	30.0	10.6	2.5	19.7	12.1	18.1	14.2	20.4	9.2	12.5	30.5	20.4	34.6	13.9	9.1	17.9	6.1	57.3	45.4	19.5	8.1	11.3	4.3	21.0	47.9	8.5	22.8	6.9	8.9	14.7	13.4	10.7	12.3	17.7	26.4	7.5	11.3	9.2	45.7	5.4	7.5	16.5	8.7	7.1	9.7	114.8	6.7	1.4	16.7	12.1	8.3	7.9	22.0	4.6	15.2	5.4	9.4	12.8	11.2	0.2	1.4	6.5	3.7	3.8	16.2	5.3	6.2	1.0	3.9	12.2	3.7	6.1	5.7	1.6	2.3	9.7	9.5	6.6	4.3	11.5	7.2	0.2	4.1	21.7	3.8	9.7	0.9	0.0	4.8	3.5	5.3	74.6	8.2	8.8	8.4	8.0	3.9	11.8	3.1	13.3	5.6	11.2	8.5	1.6	5.5	6.9	5.4	3.4	3.5	34.6	18.2	26.3	4.7	4.8	5.7	4.1	0.4	0.5	0.0	0.5	0.2	0.9	0.0	0.0	0.5	1.8	0.0	0.0	2.6	5.0	1.7	2.2	0.0	0.3	23.3	69.9	35.5	30.0	20.4	34.6	57.3	45.4	47.9	26.4	45.7	114.8	13.4	28.9	19.0	89.5	13.1	20.3	8.8	3.3	12.0	2.1	11.6	8.9	34.0	8.6	5.3	12.9	0.0	23.5	10.9	26.2	0.0	6.6	0.9	8.8	9.3	16.3	22.2	40.8	162.7	2.6	10.6	14.4	11.2	21.6	2.5	9.6	13.9	7.0	6.1	3.3	62.2	27.8	4.1	11.6	10.2	3.8	20.8	8.8	16.0	192.0	5.6	15.4	1.0	288.0	1013.6	4.9	10.7	18.8	94.4	7.2	9.3	5.4	3.4	0.8	13.1	7.0	14.3	2.0	5.3	19.9	24.9	10.4	2.7	4.4	13.6	13.5
GAS2L3		ENSG00000139354	"Growth arrest specific 2 like 3"	Q86XJ1	12	100573683-100628288	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;monocytes: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"spinal cord: 13.8"	HPA048593	Approved					NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA048593: AB_2680455"	"unprognostic (1.03e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.04e-7)"	"unprognostic (2.79e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.58e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.67e-2)"	1.8	0.8	0.1	1.6	1.4	5.6	0.8	0.1	0.7	1.2	0.5	3.3	2.7	0.7	0.4	1.6	0.3	4.8	1.5	0.5	0.1	1.3	1.0	2.5	1.3	0.5	0.5	1.1	0.5	0.2	0.2	3.5	0.5	0.3	3.8	0.4	0.5	1.1	0.8	3.4	2.7	1.6	0.3	1.4	1.4	4.0	1.4	0.9	0.6	1.2	1.2	1.6	0.5	1.1	35.4	14.0	18.6	14.8	5.7	7.3	6.2	16.2	15.3	21.3	23.8	10.4	9.5	0.6	4.8	12.8	20.8	11.8	12.0	5.9	31.0	10.0	9.1	0.0	12.2	7.0	1.9	0.0	8.0	2.9	0.6	12.8	36.1	10.1	20.2	0.0	2.2	0.0	17.7	10.4	0.0	0.2	5.9	6.5	16.7	2.4	32.5	0.8	9.2	9.6	8.4	8.1	17.0	11.7	22.2	6.5	21.3	1.9	13.6	13.6	14.3	12.2	17.8	7.4	9.3	0.0	5.3	5.6	39.3	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.1	0.1	1.4	0.1	0.7	0.5	0.1	0.5	0.5	0.5	0.3	1.4	1.1	3.6	0.0	0.0	1.0	0.2	3.4	0.4	0.5	2.8	0.2	2.0	2.2	2.0	11.5	0.2	0.0	0.0	9.9	0.4	9.8	0.0	2.7	4.5	3.6	5.5	5.6	3.6	6.9	2.5	0.7	4.5	2.2	11.2	7.4	1.3	7.2	2.5	1.4	13.9	0.0	5.9	14.2	0.0	8.0	11.1	0.5	0.6	14.7	7.2	4.7	1.5	2.2	0.0	2.5	0.3	0.3	8.2	0.7	0.3	0.6	2.6	3.4	1.0	0.1	0.0	4.8	2.7	16.0	2.3	4.7	3.7	33.9	1.0	6.8	8.3	0.6
GINS2	"Pfs2, PSF2"	ENSG00000131153	"GINS complex subunit 2"	Q9Y248	16	85676198-85690073	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 163.5;Spermatogonia: 148.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 271.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA057285	Uncertain		Approved	Nucleoplasm		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA057285: AB_2683398"	"unprognostic (3.22e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.70e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.60e-1)"	1.0	0.9	3.0	5.4	2.8	14.7	3.7	3.0	3.7	1.7	2.2	6.4	4.6	1.6	1.3	4.7	1.1	0.4	0.6	4.5	2.2	0.7	3.0	0.8	9.0	2.3	2.4	1.4	0.9	2.6	0.8	3.0	2.3	1.5	7.0	11.1	1.3	0.8	2.7	3.2	5.3	1.6	2.3	3.0	2.2	9.6	2.3	10.2	1.8	1.0	11.0	1.4	2.1	2.6	50.7	36.2	69.0	28.9	2.0	6.7	18.3	33.8	13.7	49.8	30.5	48.2	32.9	60.0	18.1	12.0	26.0	38.0	73.7	28.1	47.9	20.8	63.9	29.2	25.7	54.6	0.3	20.6	15.6	1.8	3.4	30.0	11.5	6.1	21.6	47.5	82.4	13.8	28.9	107.1	72.7	77.8	38.8	45.0	27.3	100.7	41.5	33.1	16.4	20.9	94.2	30.0	49.4	10.0	10.0	27.3	100.0	28.2	12.8	32.1	42.5	30.6	39.5	25.6	48.3	271.9	18.7	43.4	37.2	0.7	0.2	1.1	1.0	1.0	0.1	1.0	3.3	2.3	1.3	0.7	1.6	1.1	0.9	3.2	2.8	0.8	8.5	1.7	3.0	2.8	3.0	3.7	4.5	2.2	2.3	2.4	2.3	2.3	2.3	2.6	0.6	3.2	0.0	0.7	8.5	9.2	7.4	9.5	4.0	20.3	13.1	18.5	1.0	0.0	3.8	3.7	2.1	35.3	3.1	11.9	3.9	8.2	9.8	1.5	3.3	2.4	3.0	43.3	0.5	1.5	31.8	7.2	5.6	2.7	1.3	21.6	0.0	2.1	23.8	8.4	0.4	14.9	4.1	1.3	6.6	29.4	1.2	3.3	0.0	0.0	1.1	5.6	0.0	1.0	0.6	2.0	4.5	1.9	43.1	2.6	2.4	0.7	1.7	7.5	19.7	4.2	7.9	163.5	148.4	13.8	3.8	12.7	4.2	2.2	33.6	7.4
H2AX	H2AFX	ENSG00000188486	"H2A.X variant histone"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"		Yes	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	13.2	20.7	35.2	12.6	37.8	24.9	8.0	39.0	42.2	13.3	20.6	18.6	13.3	14.0	2.1	43.6	13.1	3.1	13.4	33.7	32.3	17.0	13.9	14.3	16.0	43.9	38.9	18.7	11.6	3.4	24.3	11.0	37.8	15.7	4.3	6.6	11.4	4.7	12.4	18.1	18.8	3.5	38.0	24.0	16.1	15.4	37.8	30.5	10.4	3.6	12.0	11.8	15.7	51.8	132.1	77.9	120.3	72.3	10.9	7.9	126.4	146.0	44.0	80.3	70.4	124.0	55.1	89.7	85.9	34.0	60.5	134.0	57.5	41.7	21.5	133.4	161.0	182.2	20.7	129.8	11.4	90.5	108.9	6.7	9.0	34.2	21.0	13.1	40.7	115.4	149.9	143.1	38.9	335.6	207.8	269.9	87.5	60.0	162.6	200.7	141.6	42.7	37.5	56.3	127.6	152.0	116.0	66.6	20.6	20.6	99.8	68.2	50.9	77.7	204.2	63.8	110.2	38.7	40.8	92.3	17.9	145.2	155.0	3.8	1.3	4.2	1.6	0.6	0.8	0.9	1.7	1.7	1.8	0.8	1.1	1.0	0.6	2.2	0.8	0.8	1.6	1.2	35.2	37.8	39.0	42.2	33.7	32.3	43.9	38.9	37.8	38.0	37.8	51.8	43.7	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	83.2	34.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	106.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	64.2	7.2	0.0	0.0	0.0
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 5.3;testis: 7.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	0.2	0.1	0.0	1.8	0.2	6.0	0.4	0.0	0.1	0.2	0.2	1.1	1.5	0.2	0.1	1.3	0.3	0.2	0.1	0.0	0.0	0.1	0.1	1.4	4.2	0.1	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	1.0	0.0	0.4	0.0	0.6	0.7	1.8	0.4	0.0	1.7	0.9	7.3	0.2	5.3	0.3	0.1	5.1	0.3	0.5	0.2	11.3	12.2	11.1	12.5	0.7	1.4	9.3	10.2	7.8	19.7	19.3	9.6	4.6	27.7	5.7	5.7	7.9	18.0	20.1	9.9	18.7	0.1	16.7	13.8	9.9	5.8	0.5	8.1	13.7	0.9	0.8	14.9	9.2	2.4	9.1	21.6	12.4	23.7	10.1	5.9	16.4	4.8	9.8	8.7	8.3	16.8	13.9	7.4	3.0	7.8	4.4	6.5	8.9	6.1	3.5	9.6	6.1	7.5	4.7	8.7	9.9	9.8	18.1	4.5	5.4	13.4	5.1	11.5	10.7	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388561-45554726	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612"	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	3.3	4.7	9.5	3.4	10.3	2.4	3.9	10.1	11.7	3.7	9.2	6.9	3.9	4.6	4.3	4.2	4.5	3.0	5.5	9.3	10.5	7.5	8.1	2.9	4.3	9.5	10.2	3.8	2.4	12.3	3.7	4.2	9.5	4.3	6.9	4.2	3.6	4.2	6.2	3.6	2.9	4.4	9.2	3.2	3.6	2.2	11.5	6.9	4.5	6.4	4.8	5.0	3.7	8.5	6.3	11.2	10.7	9.3	11.8	13.0	11.1	11.6	15.7	24.7	16.2	20.3	8.8	13.8	8.9	18.0	18.2	5.8	49.0	30.4	16.0	9.5	12.7	12.9	13.6	18.4	12.1	20.9	4.4	19.0	16.8	26.0	12.5	13.1	14.9	19.5	25.1	5.5	19.0	9.7	21.1	11.6	28.4	15.0	21.9	8.9	9.8	16.9	23.6	18.8	7.6	9.7	17.3	7.9	11.8	13.5	14.6	14.7	9.1	12.1	8.3	8.5	12.3	5.3	12.3	15.4	14.0	16.9	9.5	0.0	0.6	0.6	1.2	0.9	1.5	1.0	0.7	1.1	1.2	0.5	0.8	1.0	0.3	1.9	0.8	1.0	0.6	0.7	9.5	10.3	10.1	11.7	9.3	10.5	9.5	10.2	9.5	9.2	11.5	8.5	3.9	0.0	2.0	28.7	4.8	1.1	1.5	1.8	3.4	5.5	3.2	2.8	9.0	1.5	1.8	5.5	4.2	5.0	3.5	4.4	5.9	2.9	0.6	7.6	5.7	4.2	4.8	5.2	35.4	2.7	5.2	3.2	6.6	4.9	1.3	9.8	2.2	7.7	5.4	1.7	37.8	4.5	0.0	2.9	1.3	1.2	1.2	2.6	1.8	19.7	2.3	4.0	2.1	22.6	25.2	3.2	7.0	2.2	5.0	1.9	2.6	2.4	2.9	4.7	0.0	3.1	2.9	0.7	2.4	4.8	1.3	2.9	3.2	8.3	6.8	1.7
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414697-69553865	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 53.9;Glandular and luminal cells: 82.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 8.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 22.0;neutrophil: 45.9;plasmacytoid DC: 78.3"	"Group enriched"	"Detected in all"	9	"dendritic cells: 78.3;granulocytes: 45.9;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"A549: 40.0;AN3-CA: 21.4;HUVEC TERT2: 28.4;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	5.2	1.3	4.2	8.4	4.0	15.9	20.4	11.6	4.0	27.0	7.6	30.7	10.3	6.1	3.2	3.1	4.5	7.2	1.4	2.7	6.2	5.5	12.2	1.8	8.0	5.4	3.8	3.1	8.3	0.3	1.6	1.6	3.9	3.3	31.7	5.8	2.5	3.1	40.5	2.0	10.8	3.3	4.4	4.0	7.4	1.3	5.7	11.5	3.3	21.1	5.9	3.3	1.2	7.7	0.1	40.0	17.6	21.4	7.4	4.0	2.5	0.3	5.8	1.6	2.4	1.2	1.7	1.1	14.2	0.8	1.3	1.9	6.1	0.8	0.5	1.3	3.2	0.1	10.3	11.4	7.4	1.7	1.3	19.0	0.5	0.3	0.0	1.4	28.4	5.3	0.1	2.5	0.0	0.3	21.6	0.7	12.5	0.9	7.3	7.7	1.8	0.5	7.8	5.4	7.8	11.8	1.7	1.3	3.9	9.3	5.4	2.3	5.1	1.9	2.3	1.6	0.5	1.7	2.2	0.5	1.6	2.5	1.5	2.5	22.0	4.0	2.8	2.6	5.0	4.1	3.1	3.5	7.1	5.2	3.6	3.4	45.9	4.7	1.1	78.3	5.0	6.2	4.2	4.0	11.6	4.0	2.7	6.2	5.4	3.8	3.9	4.4	5.7	7.7	11.2	3.2	6.7	27.7	7.7	2.7	4.1	0.8	8.6	5.2	14.3	29.1	1.3	5.7	3.6	0.0	2.1	9.7	29.2	42.3	23.5	1.9	10.2	53.9	11.5	7.9	45.6	5.0	26.0	4.1	6.6	5.0	9.2	82.7	1.3	13.4	4.2	2.5	6.2	3.3	22.4	22.9	0.0	6.8	7.4	2.9	4.4	6.9	3.6	24.4	9.6	31.8	10.3	32.6	52.5	1.1	16.7	3.8	10.7	1.3	14.5	1.5	4.2	4.2	0.0	3.9	5.7	0.1	1.8	4.8	4.3	0.8	13.3	1.4	30.6	2.8
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161558-13211110	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.2;lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	1.2	0.1	0.0	3.3	0.1	9.2	0.8	0.1	0.2	0.4	0.1	1.7	1.5	0.4	0.1	1.9	0.2	0.2	0.1	0.0	0.0	0.1	0.7	0.3	4.8	0.0	0.1	0.2	0.1	0.2	0.1	2.1	0.1	0.1	2.2	0.1	0.3	0.0	0.5	1.1	1.2	0.8	0.0	1.0	0.8	1.5	0.2	8.1	0.3	0.1	4.5	0.6	0.6	0.1	38.0	42.0	48.6	36.9	1.6	2.9	21.2	38.7	5.9	42.7	44.0	41.3	26.4	56.7	17.1	9.9	15.7	43.3	69.0	22.8	39.2	29.7	32.9	70.9	17.6	27.7	0.0	36.6	30.8	0.6	0.8	43.3	4.0	3.5	14.0	45.0	85.2	37.6	23.4	34.0	87.7	15.7	28.9	36.3	10.3	68.3	43.0	34.6	9.8	13.7	9.7	36.6	31.3	22.0	5.9	25.2	27.7	24.9	8.6	27.0	50.3	41.0	42.4	11.7	49.0	74.3	17.2	39.6	21.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.9	0.3	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	1.7	0.0	0.0	0.0	1.8	1.7	0.4	0.8	0.0	0.0	0.8	0.5	2.4	0.0	0.8	0.0	0.0	11.8	0.8	2.4	0.0	0.4	1.0	0.3	1.2	1.4	0.0	23.5	0.4	0.2	20.9	1.8	1.1	1.0	0.0	7.2	0.0	0.2	5.3	0.0	0.4	1.2	2.0	0.6	0.4	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.4	15.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	6.4	15.8	12.9	3.6	0.4	3.4	1.2	0.8	3.1	0.4
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MMS22L	"C6orf167, dJ39B17.2"	ENSG00000146263	"MMS22 like, DNA repair protein"	Q6ZRQ5	6	97142161-97283217	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Oligodendrocytes: 52.3;Spermatocytes: 56.9;Spermatogonia: 45.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA067042			Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067042: AB_2685768"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.00e-5)"	"unprognostic (9.63e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.21e-3)"	"unprognostic (9.39e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	1.1	1.1	0.7	2.0	1.8	7.0	2.3	1.3	1.2	1.6	0.7	1.6	1.2	1.5	0.5	1.7	1.4	1.0	0.7	0.7	1.0	0.8	0.9	1.1	3.4	2.1	1.4	1.4	1.3	1.4	0.5	2.0	1.8	1.3	2.3	2.4	1.0	0.8	0.6	2.9	1.6	1.5	1.2	1.4	1.1	6.8	1.5	5.2	1.1	0.5	3.4	1.3	1.1	2.4	7.5	8.2	13.5	14.8	2.2	4.0	10.6	15.0	6.9	13.8	20.1	11.4	8.6	16.4	9.0	5.7	16.0	13.4	17.1	8.3	27.4	14.1	12.7	16.7	11.3	7.2	1.3	25.8	11.3	2.2	4.3	19.5	9.0	2.8	6.0	15.2	23.1	25.6	13.1	8.9	9.5	10.4	5.2	12.1	6.1	15.8	12.8	5.8	5.9	9.7	7.7	6.6	9.8	4.9	4.0	7.6	7.6	15.7	4.5	14.0	13.3	11.8	20.8	3.2	10.3	18.3	8.0	16.0	15.7	0.5	0.4	0.9	0.6	0.7	1.0	0.5	0.9	1.0	1.1	0.7	0.8	1.1	0.4	0.6	1.6	1.2	0.9	0.4	0.7	1.8	1.3	1.2	0.7	1.0	2.1	1.4	1.8	1.2	1.5	2.4	5.9	3.2	8.6	16.6	9.7	9.2	5.8	4.0	4.0	11.6	6.1	6.2	4.2	5.7	6.9	3.7	41.7	12.5	14.6	3.3	1.9	2.9	67.8	4.4	6.1	6.5	1.2	26.3	11.3	4.1	11.2	6.1	7.7	2.8	7.6	24.0	10.8	3.1	6.4	3.3	7.7	8.4	8.2	7.5	6.0	17.2	9.9	6.8	7.2	36.5	6.4	6.1	6.2	22.6	52.3	3.0	2.0	5.7	13.1	2.9	5.4	0.8	6.1	31.9	6.6	7.9	5.1	56.9	45.8	7.1	8.2	3.6	9.6	5.2	10.3	3.0
MRPL19	"KIAA0104, MRP-L15, RLX1, RPML15"	ENSG00000115364	"Mitochondrial ribosomal protein L19"	P49406	2	75646783-75690851	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046805, HPA056622"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046805: AB_2679816, HPA056622: AB_2683195"	"unprognostic (9.24e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.39e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.52e-3)"	"unprognostic (5.75e-2)"	"unprognostic (9.86e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.71e-3)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (2.42e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	31.3	30.1	21.8	18.9	27.4	13.9	28.6	26.5	23.5	29.1	14.8	27.8	23.7	21.7	25.2	25.0	18.1	20.7	35.0	18.8	26.7	56.0	63.7	17.8	20.3	23.4	24.4	17.4	23.6	45.2	12.2	25.7	25.4	21.6	30.9	19.3	24.1	25.1	66.4	23.9	19.9	29.0	26.8	16.9	18.4	16.5	24.9	24.3	36.9	44.8	25.1	24.5	15.1	32.5	100.7	57.5	53.3	48.3	57.0	68.1	75.6	63.4	57.0	78.5	62.2	88.5	40.6	56.5	62.1	69.2	73.8	69.5	83.7	95.8	117.8	63.2	72.4	77.4	44.4	114.3	61.0	82.9	44.5	45.6	72.4	79.7	72.3	49.6	84.1	60.8	86.4	32.3	78.5	61.9	76.1	64.9	69.9	102.9	65.2	94.5	116.5	74.5	134.1	61.9	58.8	50.2	62.2	71.2	72.4	53.3	61.1	32.8	57.0	68.3	75.4	61.2	94.6	33.3	53.8	47.1	53.9	81.0	61.1	17.7	20.2	14.2	22.1	26.8	25.1	26.8	22.7	23.8	29.7	22.7	19.9	24.6	1.4	24.4	24.9	35.0	26.5	17.2	21.8	27.4	26.5	23.5	18.8	26.7	23.4	24.4	25.4	26.8	24.9	32.5	31.8	19.2	29.6	10.7	27.4	29.1	28.6	77.8	21.1	38.3	32.4	29.5	40.2	25.8	49.4	49.7	52.1	90.3	26.3	24.0	125.2	88.7	27.6	42.7	48.4	27.7	27.6	32.8	13.9	61.1	87.3	33.7	36.7	50.3	19.0	35.8	27.1	67.6	47.3	48.8	14.3	36.5	44.7	14.6	17.0	11.2	35.4	23.7	33.8	12.2	35.0	39.6	34.0	15.1	20.0	53.6	27.7	36.5	36.5	36.1	36.5	167.7	32.8	50.9	19.7	31.4	38.1	55.5	17.6	44.3	28.3	57.7	25.3	62.2	50.7	35.6
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47403067-47663146	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 46.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes		28000	"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	8.1	7.5	8.3	12.8	10.5	15.7	15.7	14.6	10.6	9.7	12.2	11.9	7.8	11.7	14.0	9.5	12.4	5.8	10.1	9.6	9.0	8.2	6.7	8.1	23.7	8.6	8.0	8.7	6.5	14.8	6.2	11.6	9.5	8.6	15.0	34.9	8.5	7.7	7.1	11.1	9.3	8.8	8.5	10.8	8.1	16.2	7.9	32.6	15.8	7.2	25.0	7.9	6.4	8.9	114.3	35.3	103.3	57.9	7.3	21.2	64.3	62.9	33.3	80.9	76.9	72.3	50.1	141.2	84.6	23.8	56.6	49.8	78.6	37.4	122.3	68.1	55.8	99.3	42.3	65.6	7.7	97.7	34.9	12.3	11.2	68.1	19.0	19.1	45.2	3.9	165.1	34.0	63.1	44.2	119.6	75.4	195.7	69.3	45.1	151.1	182.2	84.4	35.8	57.3	85.9	91.6	58.4	49.2	48.0	83.6	46.9	38.8	18.7	55.5	70.9	57.1	74.6	20.8	63.4	180.1	33.1	72.5	35.4	3.0	1.3	4.9	8.0	4.4	9.3	6.7	7.7	10.3	2.5	7.9	12.6	13.1	1.0	14.2	3.9	3.4	11.8	6.5	8.3	10.5	14.6	10.6	9.6	9.0	8.6	8.0	9.5	8.5	7.9	8.9	14.7	9.6	11.5	18.6	13.0	8.3	7.9	14.4	8.6	17.4	7.5	7.1	15.6	5.7	12.6	9.2	45.9	19.9	14.2	6.6	3.9	11.5	17.8	21.0	11.3	13.4	3.5	54.1	59.9	8.4	20.7	12.2	7.1	18.8	12.0	28.2	5.0	1.6	11.4	11.8	58.0	12.1	14.2	4.1	4.6	22.8	5.3	5.1	8.8	16.9	5.5	22.6	17.5	35.7	54.7	7.3	5.0	6.4	12.4	2.8	5.4	4.5	23.3	41.1	0.0	9.8	9.0	56.5	50.8	9.3	6.5	5.1	12.8	24.3	13.5	3.8
MSH3	"DUP, MRP1"	ENSG00000113318	"MutS homolog 3"	P20585	5	80654652-80876815	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 95.1;Inhibitory neurons: 98.9;Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036081			Approved	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"		"HPA036081: AB_10673229"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	9.4	4.6	1.8	4.3	2.4	5.0	5.5	1.6	2.0	6.6	1.5	6.0	6.0	5.2	5.3	5.0	7.0	5.7	4.9	1.7	2.0	12.5	11.4	4.2	4.9	1.7	2.0	5.3	5.2	8.8	3.3	4.3	1.7	5.2	6.2	3.7	4.5	5.2	5.1	5.1	5.6	5.1	2.2	4.1	5.0	3.9	2.5	7.1	10.8	4.7	6.1	6.3	3.9	2.0	12.4	15.0	11.7	13.1	6.6	12.3	16.6	12.2	11.8	13.6	16.7	10.0	15.6	22.2	14.0	15.3	12.8	10.4	15.6	20.5	17.3	14.2	13.9	8.4	13.4	9.9	6.8	9.9	8.5	10.9	9.5	15.8	16.6	13.8	12.9	7.9	12.1	12.9	16.1	11.9	19.0	4.7	9.0	4.8	7.7	13.2	24.2	16.4	15.2	13.0	11.6	13.9	10.4	11.5	13.0	14.4	15.2	9.4	12.4	7.8	9.5	6.2	23.0	8.7	15.6	21.6	12.2	16.8	10.2	0.7	2.9	1.9	3.3	3.4	3.8	3.4	3.5	3.6	3.3	2.2	2.6	2.6	1.7	3.1	4.6	2.8	4.8	2.4	1.8	2.4	1.6	2.0	1.7	2.0	1.7	2.0	1.7	2.2	2.5	2.0	16.7	35.3	9.3	66.9	18.1	10.5	12.3	12.4	12.5	25.8	19.4	12.8	17.6	8.6	14.3	14.7	14.6	18.9	18.7	18.2	15.6	12.4	14.6	28.4	20.2	12.0	14.5	17.0	95.1	10.3	12.9	15.9	31.6	18.9	8.2	19.9	10.0	20.1	11.5	21.9	98.9	13.2	8.2	13.0	7.0	17.2	13.7	16.3	3.6	72.1	19.9	22.5	19.6	71.9	92.3	10.6	9.6	25.9	22.0	6.5	16.8	43.6	65.4	28.3	19.7	20.2	14.7	24.7	25.5	22.3	10.1	13.1	25.4	14.7	17.4	10.7
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;lymphoid tissue: 55.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.2	0.1	91.8	1.6	0.1	0.2	1.1	0.2	8.6	7.0	1.4	0.1	10.1	0.4	1.0	0.4	0.1	0.1	0.6	1.1	1.8	55.5	0.1	0.1	0.3	11.2	0.1	0.2	5.7	0.1	0.5	6.9	0.0	1.6	0.2	0.1	4.2	7.8	2.1	0.1	27.8	6.1	15.6	0.4	33.3	0.5	0.0	53.5	3.5	2.5	0.1	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631169-158704804	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.91e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	3.7	2.5	2.0	8.8	2.2	24.4	5.4	2.5	2.1	4.0	1.3	6.9	4.4	4.3	2.1	6.9	3.0	2.9	2.9	2.2	2.1	2.6	4.1	3.1	12.4	2.0	1.7	3.1	2.2	4.6	3.5	5.9	2.1	2.8	7.6	2.8	3.5	2.8	3.4	6.8	5.8	4.8	1.6	4.6	5.6	14.8	1.8	27.9	3.2	4.1	13.8	4.0	3.9	2.4	103.9	53.7	64.1	41.8	9.5	15.4	25.3	74.3	47.4	89.0	99.0	48.5	52.0	64.0	45.0	30.3	95.1	51.7	53.7	33.8	117.2	68.4	40.4	57.2	64.8	38.8	4.2	72.2	62.3	6.8	3.7	73.1	21.0	16.2	50.4	72.9	71.9	91.6	82.8	111.4	119.2	48.8	63.7	58.8	43.3	69.7	67.8	60.6	22.6	45.9	69.6	54.5	91.6	35.0	20.2	40.4	31.4	46.5	25.9	60.6	45.9	166.2	120.6	61.3	48.2	77.2	64.6	89.6	118.5	5.9	0.9	1.1	5.2	1.2	7.5	1.6	5.2	3.6	2.3	1.0	1.6	1.8	0.7	5.2	5.1	1.1	7.2	2.2	2.0	2.2	2.5	2.1	2.2	2.1	2.0	1.7	2.1	1.6	1.8	2.4	3.6	6.4	1.5	3.9	4.1	4.0	2.1	2.8	1.8	3.9	3.7	3.3	4.8	2.8	4.6	1.8	0.0	6.7	5.1	3.4	0.0	2.3	15.1	4.0	4.6	4.3	0.0	19.6	10.7	3.3	10.4	4.5	4.1	5.9	1.3	12.6	2.9	2.6	7.3	8.4	7.2	2.9	2.0	3.8	5.2	7.2	2.8	4.4	1.8	3.7	2.7	2.1	2.1	10.1	10.7	2.3	0.4	4.1	11.0	1.1	0.3	1.3	6.0	2.8	6.6	4.3	5.7	48.2	18.5	6.1	2.0	2.6	4.9	5.0	5.7	3.0
NIPSNAP1		ENSG00000184117	"Nipsnap homolog 1"	Q9BPW8	22	29554808-29581327	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 291.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 116.7;Proximal tubular cells: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059227	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA059227: AB_2683951"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (8.82e-6)"	"unprognostic (2.81e-2)"	"unprognostic (8.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.72e-1)"	10.7	43.9	35.4	17.5	37.8	15.5	31.5	31.8	38.5	21.5	33.4	37.4	67.0	19.4	24.9	25.8	26.8	19.8	21.8	37.6	41.7	117.8	291.8	17.8	23.3	37.1	36.5	32.3	24.4	68.0	36.5	17.3	39.3	23.9	38.5	46.2	26.0	27.2	4.4	20.6	49.2	17.8	30.7	19.1	29.3	11.9	36.7	36.7	32.9	5.4	28.3	20.1	18.3	31.7	69.1	81.1	165.3	206.9	29.2	59.4	30.7	39.5	70.7	53.2	68.7	55.5	90.6	48.8	76.8	56.9	56.0	68.2	87.7	100.7	65.1	98.8	90.5	16.8	37.0	173.5	44.1	36.5	23.0	59.5	50.8	44.1	55.0	129.0	73.4	105.3	31.8	78.9	49.2	156.4	59.3	50.1	140.0	106.2	67.5	115.9	51.7	142.6	128.3	59.1	203.9	179.5	46.1	83.2	92.1	79.5	137.1	57.7	34.7	23.2	79.6	28.6	31.9	106.4	56.5	45.6	62.1	57.3	39.4	10.8	9.4	15.9	34.2	17.4	41.2	29.0	34.4	36.2	21.6	27.3	32.6	39.5	13.8	39.5	10.7	11.0	44.9	22.1	35.4	37.8	31.8	38.5	37.6	41.7	37.1	36.5	39.3	30.7	36.7	31.7	7.4	25.6	15.7	6.8	16.3	4.8	12.6	15.8	18.8	22.6	25.5	18.5	22.9	28.6	18.6	42.3	10.4	44.4	9.2	14.4	68.4	45.8	2.1	6.2	13.7	10.1	41.9	24.6	16.9	18.5	14.6	14.2	25.5	12.0	26.0	33.5	11.7	116.7	14.4	10.1	19.9	31.5	26.4	8.7	4.3	6.1	11.1	8.1	5.4	3.7	21.3	38.7	28.8	6.6	10.3	17.8	20.2	14.3	7.3	6.8	35.2	134.7	9.8	24.4	13.1	7.2	12.3	1.4	8.3	20.5	8.1	14.8	20.5	48.1	47.4	8.8
ORC6	ORC6L	ENSG00000091651	"Origin recognition complex subunit 6"	Q9Y5N6	16	46689643-46698394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.3;lymphoid tissue: 7.4;testis: 9.6"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 56.7;Spermatocytes: 102.6;Spermatogonia: 108.9;Theca cells: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016330, HPA072587"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		Yes	No			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB016330: AB_670295, HPA072587: AB_2686537"	"unprognostic (3.47e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.15e-6)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (3.53e-4)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.50e-4)"	"unprognostic (3.97e-2)"	"unprognostic (3.90e-14)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.98e-2)"	0.3	0.7	2.0	2.2	1.6	10.3	0.6	1.5	1.9	0.7	1.0	1.7	1.5	0.8	1.1	4.1	0.4	0.6	1.5	1.9	1.8	0.4	0.9	0.6	7.4	1.5	1.9	0.4	0.3	0.7	0.6	3.3	1.7	0.3	1.9	0.3	0.7	0.2	0.1	1.1	1.5	1.0	1.6	2.4	0.8	9.6	1.8	6.2	0.5	0.3	7.3	1.2	1.3	1.8	28.6	27.4	43.7	33.9	5.4	6.8	31.6	54.2	20.2	59.3	30.9	39.3	18.0	35.6	27.1	10.5	29.1	29.9	57.9	15.1	50.4	17.2	46.4	27.9	13.2	40.1	6.6	46.5	23.7	1.8	2.6	32.4	17.1	9.3	20.0	30.1	36.0	17.4	35.9	26.9	65.6	60.7	48.1	20.7	76.0	78.6	80.6	35.8	14.9	9.8	52.2	30.4	24.5	29.8	18.1	34.9	15.6	37.9	11.6	53.7	34.6	33.6	51.8	12.5	18.9	123.2	22.2	29.5	40.1	0.0	0.3	0.3	0.9	0.7	0.4	0.7	0.5	0.5	0.6	1.4	0.8	0.3	0.0	0.8	0.8	1.0	1.2	0.7	2.0	1.6	1.5	1.9	1.9	1.8	1.5	1.9	1.7	1.6	1.8	1.8	1.6	3.2	14.5	1.0	8.8	6.6	2.2	3.6	8.6	6.6	4.1	5.8	3.7	1.5	6.3	5.5	4.2	39.3	6.0	9.5	1.9	2.5	13.2	6.5	7.5	4.3	1.8	45.4	6.3	0.7	40.9	8.0	7.1	9.4	1.3	56.7	0.7	9.9	15.7	11.8	2.7	12.4	6.1	3.8	11.9	8.9	2.8	7.7	33.8	2.8	1.2	2.5	2.1	0.0	2.0	2.1	1.4	3.4	18.5	2.6	2.3	1.0	10.7	10.2	0.0	5.1	7.3	102.6	108.9	16.9	6.0	10.9	7.5	47.5	14.4	2.7
PCLAF	"KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15"	ENSG00000166803	"PCNA clamp associated factor"	Q15004	15	64364304-64387687	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 128.6;lymphoid tissue: 73.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 82.2;Extravillous trophoblasts: 160.2;Granulosa cells: 48.8;Hofbauer cells: 110.2;Syncytiotrophoblasts: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	4	"T-reg: 23.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 23.6"	"Low cell line specificity"	"Detected in all"											HPA047929			Supported	Centrosome		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA047929: AB_2680215"	"unprognostic (5.34e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (4.38e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (9.77e-15)"	"unprognostic (5.59e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.22e-1)"	2.1	1.4	0.9	22.9	1.0	128.6	3.9	1.4	1.1	1.7	0.8	19.0	14.7	4.5	1.2	15.2	1.3	2.5	0.4	0.9	0.6	1.2	3.6	2.5	49.5	1.0	0.8	0.4	1.9	0.8	0.5	8.7	0.9	2.0	22.6	0.3	2.3	0.3	0.4	6.7	15.8	5.0	0.5	7.4	8.1	1.1	1.0	73.8	2.2	0.1	47.1	7.9	4.9	1.9	212.6	165.8	154.4	140.8	15.9	60.9	134.4	146.2	84.8	185.4	276.4	198.4	202.1	343.7	46.4	57.4	64.8	153.6	340.7	83.1	235.3	192.5	124.8	352.5	202.5	209.8	1.5	285.3	153.8	20.0	7.9	156.4	31.9	52.3	168.9	175.9	201.3	104.4	248.1	187.8	268.0	605.5	73.9	179.9	73.4	416.6	353.8	247.1	115.9	200.2	19.1	86.7	112.8	105.2	69.3	78.9	153.8	365.3	36.3	158.4	308.6	177.8	386.7	65.5	223.4	229.0	67.7	512.9	108.5	2.4	0.3	0.9	1.4	0.2	0.2	2.0	4.4	4.2	2.8	0.6	0.5	1.0	2.7	5.7	0.4	0.3	23.6	2.3	0.9	1.0	1.4	1.1	0.9	0.6	1.0	0.8	0.9	0.5	1.0	1.9	0.5	9.6	11.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	27.5	25.5	0.0	0.0	5.0	1.8	0.0	82.2	8.3	0.0	1.9	6.5	0.0	18.6	10.4	8.5	0.0	0.0	0.0	3.0	160.2	25.4	0.0	13.8	3.8	48.8	0.0	0.0	110.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	4.3	0.0	0.0	3.0	3.6	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	42.1	5.8	7.6	0.0	0.0
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.3;Erythroid cells: 17.7;Granulosa cells: 15.1;NK-cells: 15.5;Theca cells: 18.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	0.7	1.0	0.8	2.6	0.8	3.8	0.4	0.7	1.3	0.9	0.7	2.4	1.9	0.8	0.1	3.1	0.7	0.8	0.9	0.7	1.2	0.6	0.6	1.0	4.6	1.4	1.0	0.4	0.2	0.2	0.5	0.9	1.1	1.7	1.0	0.1	0.6	0.7	0.3	1.0	2.6	1.2	0.9	4.8	1.8	2.5	1.2	3.6	0.5	0.1	3.3	1.5	1.4	0.8	7.7	8.7	21.1	8.6	3.7	4.3	7.8	7.4	3.9	7.3	5.6	14.0	12.6	9.3	3.0	3.6	6.8	20.9	21.8	6.2	2.7	14.8	8.0	10.8	28.5	10.2	1.9	4.3	8.4	2.5	0.0	3.2	2.6	1.8	7.5	13.6	7.2	18.0	7.0	6.7	4.7	17.9	17.2	9.7	6.0	9.7	7.0	13.0	4.1	4.3	8.7	5.6	5.7	6.3	3.3	9.2	7.0	4.7	5.2	4.4	22.6	7.0	14.0	14.3	14.3	9.0	4.2	18.8	6.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.8	0.7	1.3	0.7	1.2	1.4	1.0	1.1	0.9	1.2	0.8	1.2	0.0	1.1	3.6	6.5	1.9	0.8	0.6	0.0	0.5	0.6	0.6	1.9	0.0	0.1	0.0	0.0	5.1	7.5	3.2	0.0	0.0	21.3	0.4	4.4	2.3	0.0	17.7	2.6	0.0	6.5	5.6	3.6	0.7	0.0	15.1	5.3	0.5	5.8	0.0	1.0	2.4	0.0	5.1	2.0	2.3	1.5	4.5	0.0	1.9	0.1	0.8	15.5	3.5	0.1	0.2	0.1	2.2	9.7	1.1	0.2	0.1	0.1	1.2	6.6	4.2	3.5	0.8	2.0	1.6	1.0	1.1	7.5	18.3	6.2	1.3
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980479	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.6;testis: 56.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 29.0;Extravillous trophoblasts: 52.0;Plasma cells: 22.9;Spermatocytes: 114.7;Spermatogonia: 46.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	6	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA068860: AB_2686050"	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.33e-4)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	1.1	1.0	0.4	6.8	0.5	27.6	0.6	1.6	1.4	2.2	0.2	3.9	2.8	0.6	0.3	11.5	0.4	0.6	0.9	0.5	0.2	0.9	1.6	2.0	8.0	0.7	0.6	0.3	1.8	0.1	1.0	3.1	0.8	1.0	1.3	17.4	1.9	0.1	2.4	4.4	4.0	1.0	0.5	5.6	3.3	56.9	0.7	9.6	0.5	0.0	4.5	0.7	3.3	0.8	84.2	57.0	22.0	31.2	0.3	0.9	64.0	65.5	15.1	40.0	38.4	45.0	49.3	54.2	29.2	7.9	24.2	106.7	15.7	20.7	7.2	71.7	56.7	27.9	52.7	40.0	0.0	31.2	73.6	0.7	1.8	24.0	6.5	5.0	8.4	57.6	80.6	87.0	13.5	127.5	83.6	88.0	37.9	39.3	34.4	93.7	51.2	100.7	7.8	17.7	42.6	46.7	31.9	77.7	23.9	12.1	44.7	56.9	7.7	53.2	69.7	77.3	68.0	67.6	54.2	94.0	19.4	40.0	61.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.3	0.4	0.5	1.6	1.4	0.5	0.2	0.7	0.6	0.8	0.5	0.7	0.8	0.0	0.0	1.1	0.0	1.9	2.5	1.3	2.1	0.6	0.4	1.5	1.3	0.6	1.5	1.6	1.8	6.2	16.0	1.3	5.0	0.0	0.8	20.0	0.6	0.8	0.8	1.8	29.0	0.4	0.6	52.0	2.5	3.1	1.9	0.0	4.5	0.0	0.4	11.8	0.0	0.2	3.6	6.1	2.1	1.8	8.6	0.3	1.9	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.6	0.3	0.4	22.9	0.7	0.3	0.1	0.2	7.1	0.0	0.1	2.6	114.7	46.1	11.2	0.6	7.4	4.2	0.5	8.6	2.0
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880893-127899224	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 22.6;lymphoid tissue: 14.4;testis: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.9;Late spermatids: 87.5;Spermatocytes: 53.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.0	1.1	0.4	4.9	0.5	22.6	2.0	0.2	0.7	0.9	0.1	3.5	2.8	1.5	0.6	3.2	1.3	1.1	0.5	0.5	0.6	0.6	0.8	0.9	7.4	0.5	0.5	1.0	0.4	0.6	0.2	3.6	0.4	0.9	4.3	2.1	0.9	0.9	0.1	2.3	2.9	1.8	0.4	1.6	2.0	22.6	0.6	14.4	0.9	0.7	7.3	1.3	1.4	0.4	26.1	12.1	44.3	22.9	1.5	4.2	20.1	24.9	17.6	32.4	33.3	17.0	26.1	34.9	9.0	13.9	26.3	16.7	31.6	19.9	49.6	27.4	13.1	31.6	20.0	16.0	0.5	45.2	35.9	1.4	2.0	29.7	13.6	5.9	25.3	26.3	37.5	45.2	27.6	18.2	69.9	20.1	20.7	26.3	13.6	36.0	30.9	12.1	10.8	16.4	24.4	20.0	15.8	14.2	7.6	18.7	11.5	19.3	11.0	25.3	24.4	17.4	31.4	23.1	27.4	49.0	13.0	33.7	28.7	0.0	0.1	0.4	0.4	0.2	0.3	0.1	0.5	0.5	0.2	0.2	0.1	0.6	0.0	0.4	0.1	0.1	1.2	0.2	0.4	0.5	0.2	0.7	0.5	0.6	0.5	0.5	0.4	0.4	0.6	0.4	1.6	0.0	0.6	0.0	1.6	1.7	0.9	1.7	1.2	1.8	1.0	0.9	0.9	0.0	0.6	1.8	0.0	6.0	1.9	2.0	0.0	0.6	65.9	4.7	1.0	1.0	2.4	19.6	0.8	0.4	12.9	1.6	4.1	2.0	1.3	7.5	0.4	0.5	3.7	0.0	0.8	3.3	6.1	1.3	0.6	87.5	2.8	1.5	0.0	1.0	1.2	1.1	1.0	1.0	1.2	0.1	0.5	0.4	8.7	0.7	0.5	0.6	3.7	0.8	0.0	0.4	3.6	53.5	13.4	6.8	0.9	3.8	2.1	0.8	4.5	1.7
POLA2	FLJ21662	ENSG00000014138	"DNA polymerase alpha 2, accessory subunit"	Q14181	11	65261920-65305589	"Metabolic proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.2;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA037570	Supported		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA037570: AB_10672280"	"unprognostic (2.28e-1)"	"prognostic favorable (4.61e-4)"	"unprognostic (1.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.09e-8)"	"unprognostic (1.60e-3)"	"unprognostic (8.26e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.25e-3)"	3.3	2.6	1.9	5.3	2.9	6.9	3.5	4.8	3.3	4.5	1.7	5.3	3.6	5.0	3.3	4.5	3.8	1.8	2.9	1.9	1.5	3.5	3.7	3.5	10.0	4.5	2.8	5.1	3.3	3.2	1.9	2.1	3.7	3.0	4.9	3.6	4.2	3.1	3.1	5.1	4.2	4.1	3.1	5.7	3.8	5.2	2.6	15.9	3.3	3.4	13.2	3.2	3.2	7.0	32.6	21.9	47.3	20.4	3.7	3.6	19.5	25.6	15.9	64.4	43.3	6.9	24.0	48.1	20.4	11.0	35.5	18.9	38.8	25.1	61.1	21.3	14.7	32.4	39.4	10.4	0.9	33.5	25.6	3.7	2.9	47.4	8.5	10.3	14.6	20.2	30.2	25.3	44.4	34.9	62.6	13.2	38.6	16.1	16.2	33.4	29.9	40.7	14.1	21.8	32.5	18.1	14.9	15.9	7.9	29.7	28.6	14.1	3.9	25.4	18.7	19.8	16.0	12.0	14.7	45.0	14.9	18.8	33.7	10.0	5.2	2.3	3.8	3.2	4.5	3.9	4.2	4.2	7.4	3.9	3.5	3.1	1.4	3.8	1.7	5.9	4.6	5.3	1.9	2.9	4.8	3.3	1.9	1.5	4.5	2.8	3.7	3.1	2.6	7.0	2.6	0.0	3.4	1.0	5.1	1.7	4.2	5.7	2.2	2.2	3.0	2.3	2.9	7.2	3.7	5.5	2.1	15.6	4.3	3.0	3.9	5.3	2.7	1.8	2.9	3.7	3.0	23.2	4.3	3.4	19.0	7.7	5.6	2.5	0.0	11.0	5.3	2.1	9.7	3.3	3.6	3.5	2.0	2.8	3.7	4.0	7.5	5.3	0.0	12.2	8.0	2.2	5.2	1.5	8.7	4.9	2.2	7.5	10.4	3.4	1.7	2.0	3.2	5.4	6.6	19.6	5.0	23.7	17.7	4.3	1.4	7.3	5.5	4.0	6.3	3.7
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105273218-105454062	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.7;Syncytiotrophoblasts: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	17.3	17.4	7.2	14.6	8.1	14.3	17.7	7.4	12.0	15.2	7.8	32.1	23.6	15.8	12.1	21.1	13.0	8.7	22.5	8.8	7.3	11.3	19.0	16.2	13.6	6.7	7.7	16.0	19.2	20.5	13.0	17.8	6.8	11.6	37.5	15.4	18.6	9.0	84.8	33.4	25.6	15.3	6.6	14.3	18.7	21.4	8.8	16.4	12.3	46.9	16.2	21.4	17.5	8.5	22.3	26.9	27.9	32.1	63.1	37.1	27.7	28.6	27.0	37.2	39.0	35.9	14.2	28.5	26.8	33.9	35.0	33.3	41.8	86.5	42.7	41.8	37.4	38.1	21.7	40.0	25.3	40.5	26.2	35.8	53.4	27.6	71.7	28.0	35.4	50.1	67.4	49.8	45.5	38.8	25.8	41.4	27.9	44.2	25.0	41.1	48.4	18.3	28.2	53.8	36.0	51.8	25.3	42.0	21.7	35.3	17.9	61.9	36.1	17.3	23.9	21.6	36.2	14.2	9.7	38.5	30.4	42.6	56.6	5.5	15.2	8.4	16.3	16.8	16.8	9.3	14.2	17.1	16.5	6.9	12.9	15.5	0.8	19.9	22.7	7.0	13.6	13.5	7.2	8.1	7.4	12.0	8.8	7.3	6.7	7.7	6.8	6.6	8.8	8.5	6.3	3.2	6.7	22.9	10.1	10.8	6.8	12.0	5.7	5.1	6.0	5.5	14.8	7.2	13.6	7.3	14.6	28.2	14.5	19.3	5.9	10.4	1.4	6.6	15.1	10.1	19.3	11.2	79.7	11.7	35.9	10.6	24.5	11.6	13.4	11.2	7.5	15.1	15.0	13.5	48.3	29.4	10.2	14.2	10.8	3.2	10.8	13.3	5.4	27.2	19.1	3.3	5.2	28.6	18.7	18.0	29.1	9.1	11.0	5.3	18.5	8.8	4.8	10.4	0.0	8.3	10.3	3.9	18.8	12.9	8.5	67.9	16.1	14.4	38.2	8.5
PRIM1		ENSG00000198056	"DNA primase subunit 1"	P49642	12	56731296-56752374	"Predicted intracellular proteins"	"DNA replication, Transcription"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 56.4;Spermatocytes: 118.2;Spermatogonia: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040010	Uncertain					NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA040010: AB_10805599"	"unprognostic (3.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (2.40e-8)"	"unprognostic (4.68e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.53e-2)"	3.7	3.2	2.0	7.0	2.8	28.2	9.9	5.5	2.8	3.7	1.2	7.9	4.5	5.0	4.2	4.4	5.3	2.9	2.3	1.9	2.0	3.0	7.5	4.9	12.3	2.5	2.2	8.9	6.1	6.1	2.1	4.8	2.6	3.6	11.2	8.3	3.9	3.9	4.6	7.8	7.7	5.8	2.0	6.9	5.4	14.4	2.3	18.8	5.0	5.6	14.4	3.8	3.1	4.3	43.0	37.9	52.1	29.2	5.1	9.1	57.8	34.7	28.7	62.1	59.8	42.0	54.4	83.0	27.4	15.8	26.0	40.4	60.3	39.9	68.8	40.7	40.4	106.2	22.6	36.8	1.2	129.3	43.2	4.2	7.2	55.8	22.1	8.8	22.6	92.1	105.5	123.8	35.4	33.6	76.8	54.4	53.5	32.0	47.1	85.0	81.4	70.9	15.0	35.4	51.0	46.0	41.4	20.6	19.9	36.2	67.2	52.8	10.9	32.2	70.7	33.1	46.4	45.1	94.5	45.3	19.4	55.4	40.9	2.5	1.9	4.4	9.1	4.0	9.5	11.3	11.2	8.5	3.9	12.2	14.0	10.7	1.0	6.8	7.1	7.5	10.0	5.3	2.0	2.8	5.5	2.8	1.9	2.0	2.5	2.2	2.6	2.0	2.3	4.3	6.9	6.4	6.8	4.6	10.4	3.8	10.7	10.0	4.6	5.1	7.0	7.2	3.2	2.8	6.1	7.3	6.2	14.9	8.7	2.5	0.0	5.8	6.2	4.1	3.9	6.4	1.2	56.4	5.7	7.2	27.0	5.4	5.6	3.3	3.8	10.0	5.7	4.7	11.8	20.2	10.6	4.6	2.0	8.1	3.1	4.3	7.2	6.5	3.6	2.8	7.9	5.7	8.2	8.0	7.8	2.7	2.2	4.9	9.7	2.2	2.0	2.5	6.0	12.7	13.1	8.2	8.8	118.2	107.2	5.1	4.0	4.5	12.8	3.0	9.4	5.0
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.9;lymphoid tissue: 43.0;testis: 45.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 55.7;Extravillous trophoblasts: 49.4;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	5.0	2.5	5.5	13.7	8.2	38.9	7.1	6.9	6.3	5.2	3.2	16.7	10.5	5.3	1.5	21.3	4.4	6.4	2.8	5.0	6.0	9.2	4.7	6.2	23.9	6.7	7.1	2.4	2.7	5.8	1.4	14.0	6.5	3.3	18.7	5.3	4.8	3.4	4.9	14.4	11.6	12.5	5.5	6.5	9.8	45.5	7.6	43.0	3.3	4.8	30.2	7.7	8.0	7.0	193.0	174.5	135.8	86.8	24.8	29.7	113.0	195.0	97.0	207.3	140.3	174.6	144.7	107.5	86.0	108.3	99.9	127.1	137.7	93.6	219.9	203.0	85.4	137.9	165.8	58.1	8.4	146.1	109.0	16.2	17.2	140.7	111.4	60.3	71.7	96.4	101.6	159.6	197.0	136.8	122.5	72.6	96.2	108.9	112.9	113.9	163.5	78.3	54.9	95.7	113.9	97.5	161.7	102.7	53.0	68.8	199.7	64.8	64.9	136.2	119.1	86.8	144.7	83.3	225.2	126.6	67.7	97.0	81.1	24.1	3.2	4.7	6.5	4.1	5.7	8.2	7.9	9.2	2.8	4.3	4.6	6.1	0.7	11.0	2.6	1.8	19.1	5.8	5.5	8.2	6.9	6.3	5.0	6.0	6.7	7.1	6.5	5.5	7.6	7.0	2.0	6.4	6.4	2.9	4.2	12.9	2.5	4.9	6.2	1.5	4.8	5.1	1.5	2.8	3.3	5.5	4.2	21.8	4.4	3.1	19.6	1.9	15.2	2.2	3.1	2.7	0.0	55.7	7.5	2.2	49.4	5.9	7.7	4.0	2.5	14.2	5.3	2.7	13.1	1.7	8.0	5.7	20.3	11.3	8.0	17.7	1.5	7.1	1.8	1.0	4.5	2.7	6.2	6.0	12.3	2.0	1.0	3.8	10.9	2.8	1.1	2.1	2.3	0.8	13.1	3.1	5.5	79.6	32.2	19.5	12.9	8.6	6.9	2.2	11.6	2.9
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.7;testis: 24.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Extravillous trophoblasts: 67.2;Spermatocytes: 53.6;Spermatogonia: 24.8;Syncytiotrophoblasts: 25.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.9"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010381, HPA039310"	Enhanced		Supported	"Nucleoli rim,Cytosol"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoli rim"	Cytosol	"CAB010381: AB_2253533, HPA039310: AB_2676434"	"prognostic unfavorable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	0.9	0.6	0.4	5.5	0.5	10.5	1.9	1.7	0.7	1.0	0.6	8.3	3.2	1.2	0.4	4.2	0.7	1.3	0.6	0.4	0.5	0.5	1.3	1.1	11.0	0.4	0.3	0.6	1.4	0.5	0.2	6.8	0.5	0.8	9.1	0.3	1.0	0.3	1.0	3.1	4.1	2.4	0.1	2.4	1.8	24.3	0.3	15.7	0.6	0.5	13.3	1.7	1.5	0.5	33.8	16.1	33.4	16.3	4.4	7.8	31.1	54.9	16.5	43.3	43.8	35.4	22.1	20.4	26.8	20.9	18.9	67.7	56.6	22.1	42.3	39.0	22.2	47.7	28.2	30.4	0.4	37.9	28.5	1.7	2.9	30.0	13.5	6.4	22.5	48.5	59.6	55.8	36.6	28.5	54.4	43.6	35.2	69.2	19.0	61.0	49.0	30.7	15.4	45.3	15.4	27.0	23.6	41.4	8.5	39.2	27.0	39.4	9.9	32.8	22.2	48.7	27.2	12.0	65.1	59.8	16.3	78.0	33.5	1.3	0.6	1.7	2.4	1.3	0.6	1.7	2.5	3.2	1.0	1.1	0.6	1.2	1.2	1.8	1.4	0.9	5.9	1.2	0.4	0.5	1.7	0.7	0.4	0.5	0.4	0.3	0.5	0.1	0.3	0.5	0.0	0.0	0.0	0.3	1.9	3.6	1.5	2.0	0.0	0.8	0.1	0.0	0.9	0.0	1.0	0.0	0.0	35.3	1.4	3.0	0.0	0.0	5.7	0.2	0.2	1.0	0.0	16.0	1.6	0.0	67.2	1.3	2.0	0.2	0.0	0.6	2.2	0.2	12.7	0.0	1.2	5.3	2.0	1.6	1.7	5.3	0.6	0.5	0.0	1.0	0.3	0.3	2.1	0.5	0.6	0.1	5.0	0.7	8.2	0.9	1.0	0.0	0.1	0.0	0.0	0.5	0.9	53.6	24.8	3.9	1.6	25.3	1.2	0.1	8.0	2.1
RAD51AP1	PIR51	ENSG00000111247	"RAD51 associated protein 1"	Q96B01	12	4538798-4560047	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Meiosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.9;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.4;Erythroid cells: 47.8;Extravillous trophoblasts: 34.1;Hofbauer cells: 40.8;Late spermatids: 68.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051499			Approved	Nucleoplasm		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051499: AB_2681508"	"unprognostic (1.03e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (6.30e-2)"	"unprognostic (5.25e-3)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.29e-3)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.44e-15)"	"unprognostic (2.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.88e-2)"	"unprognostic (3.75e-2)"	0.9	0.8	0.3	4.8	0.4	16.9	2.7	0.4	0.7	0.9	0.3	5.2	5.2	1.2	0.6	3.2	1.0	1.1	0.5	0.3	0.3	0.8	1.8	1.4	8.9	0.4	0.4	0.5	0.4	0.6	0.3	3.8	0.4	1.3	6.5	1.5	1.0	1.0	0.5	3.2	4.8	1.9	0.4	3.4	2.7	6.3	0.4	14.4	1.0	0.6	7.9	1.7	1.3	0.5	37.5	13.0	45.3	22.7	2.7	5.7	53.0	48.2	21.2	52.6	68.9	35.4	35.4	48.6	7.0	10.4	24.7	23.1	31.8	14.5	80.0	38.7	27.0	61.4	21.6	24.8	0.6	56.6	29.9	1.2	1.5	31.6	30.4	7.5	21.4	33.0	39.2	54.4	33.7	13.6	46.5	20.5	110.4	36.3	14.4	46.0	54.3	19.2	16.1	18.3	15.1	16.6	35.9	27.7	11.6	45.5	11.3	32.6	9.5	35.5	36.5	38.8	52.4	7.8	10.0	93.3	13.3	40.0	29.4	0.0	0.5	0.7	0.1	2.3	0.5	3.1	0.4	1.0	0.4	3.4	0.1	0.2	0.0	1.4	2.0	6.9	1.0	0.6	0.3	0.4	0.4	0.7	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.5	1.4	0.0	0.5	0.7	6.1	5.2	2.3	6.6	1.2	3.1	3.4	5.7	1.4	2.8	4.5	0.0	4.2	20.3	11.3	5.7	0.0	3.0	33.4	3.3	2.9	2.9	2.4	47.8	2.7	2.7	34.1	5.2	6.1	3.6	1.3	22.6	2.5	1.2	40.8	0.0	1.1	6.4	16.2	6.2	5.6	68.1	1.2	10.1	0.0	3.7	6.8	2.7	3.1	0.5	2.4	1.5	0.8	1.5	15.5	1.0	1.2	1.5	0.9	4.8	0.0	2.4	4.2	35.9	25.0	10.0	2.6	4.7	4.6	2.0	14.6	2.7
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095997	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.3;Inhibitory neurons: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	2.0	1.6	1.2	4.8	2.6	14.5	2.8	8.3	1.8	2.3	0.7	2.8	2.4	2.8	1.3	2.9	1.9	2.0	1.8	1.0	1.9	1.6	1.4	2.2	7.3	2.0	1.9	4.4	2.4	2.6	1.1	3.4	2.2	2.0	3.5	4.0	1.5	1.4	6.9	3.1	2.5	2.8	1.4	3.4	2.7	3.1	2.0	8.8	2.7	7.9	6.7	2.0	2.2	3.4	24.8	15.8	19.4	13.1	4.9	6.4	12.4	28.2	12.6	23.9	24.6	16.8	13.5	27.5	7.9	11.8	14.0	23.8	17.5	18.2	39.7	9.7	9.4	27.2	18.1	14.3	3.0	35.3	18.2	3.0	2.5	31.6	11.1	4.0	13.6	17.9	20.1	25.8	13.7	10.5	33.1	11.7	5.7	12.5	15.3	21.3	57.7	20.9	5.5	12.2	4.6	11.5	30.8	17.6	8.2	6.2	11.3	25.3	9.1	42.0	15.9	38.9	24.8	8.6	16.4	27.7	30.2	24.4	21.1	0.9	0.7	1.4	2.7	0.8	2.3	3.0	3.0	2.5	1.3	2.1	3.2	2.7	0.3	2.2	1.2	3.0	4.5	0.9	1.2	2.6	8.3	1.8	1.0	1.9	2.0	1.9	2.2	1.4	2.0	3.4	3.5	6.4	11.0	10.4	8.7	2.4	1.5	1.7	4.0	5.9	2.5	1.7	2.9	1.5	6.1	0.0	2.1	5.9	6.5	1.8	0.0	1.8	1.5	2.2	4.3	3.3	1.2	23.3	14.7	1.1	5.1	4.6	2.6	2.9	8.8	9.0	2.2	1.4	4.5	3.3	22.8	1.9	0.0	3.0	3.2	0.6	2.1	6.8	1.8	6.5	4.7	3.1	7.2	19.6	18.5	0.9	3.6	3.0	14.1	0.8	1.0	0.7	0.9	12.2	6.6	8.5	4.1	17.5	8.7	5.3	1.3	3.8	11.7	6.4	3.5	0.9
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 55.7;Spermatocytes: 86.7;Spermatogonia: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favorable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.0	6.0	7.3	19.3	7.6	41.5	13.8	8.9	11.9	8.8	7.4	15.4	10.9	14.1	6.6	11.8	10.8	7.7	9.1	7.5	7.5	7.3	10.7	7.2	31.5	7.3	7.4	15.0	11.0	8.0	5.7	14.5	7.6	7.7	20.4	11.2	8.6	7.0	8.3	11.7	11.7	17.6	7.5	14.3	10.4	22.7	8.1	35.7	7.3	6.7	34.5	7.8	8.2	8.3	167.3	56.2	130.8	83.6	18.8	20.1	103.0	78.9	49.9	123.6	135.8	84.8	77.9	119.5	177.4	38.0	118.0	86.1	116.5	77.5	151.1	180.5	102.5	123.3	86.3	86.3	14.6	131.8	79.5	17.3	27.5	84.9	66.1	27.6	42.0	183.8	97.9	165.4	85.3	79.7	167.2	122.8	116.0	148.1	76.0	129.9	112.5	164.3	44.9	60.7	126.3	63.3	97.3	107.6	90.3	97.6	183.0	123.7	19.6	74.4	93.3	125.8	239.9	91.9	216.9	398.9	65.3	142.8	100.0	0.0	2.8	9.7	11.5	4.2	11.1	13.1	11.4	12.0	5.0	15.1	11.2	10.2	0.6	9.8	14.7	9.6	21.8	7.7	7.3	7.6	8.9	11.9	7.5	7.5	7.3	7.4	7.6	7.5	8.1	8.3	5.1	0.0	2.2	3.3	14.0	6.0	15.3	18.1	5.2	16.1	4.1	8.1	7.5	5.7	9.3	11.0	0.0	43.0	9.7	4.4	5.9	15.3	27.3	5.6	7.0	6.1	1.2	46.3	5.2	16.6	55.7	8.3	6.6	6.0	8.2	25.3	6.1	3.0	23.9	8.4	4.4	7.1	10.2	2.6	4.9	10.0	10.5	6.2	1.8	4.7	12.2	14.9	9.2	2.5	4.3	9.2	4.1	7.9	23.8	3.8	2.8	7.9	7.9	14.4	6.6	10.2	13.1	86.7	50.5	7.9	3.0	11.2	9.6	8.8	13.9	4.7
RFC5	RFC36	ENSG00000111445	"Replication factor C subunit 5"	P40937	12	118013588-118033130	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041037	Supported		Approved	Nucleoplasm		NA	NA		6500	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041037: AB_10805834"	"unprognostic (9.63e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (5.12e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.06e-1)"	5.9	5.8	3.7	10.5	4.4	33.8	10.7	5.9	4.9	8.6	4.2	10.3	9.8	11.1	5.4	9.3	9.5	6.7	5.4	6.0	2.9	8.7	13.0	6.8	16.4	3.3	3.2	15.6	7.6	7.1	4.7	7.3	3.2	7.9	12.6	11.5	5.8	8.0	5.6	12.9	9.1	7.7	3.8	8.0	7.2	8.3	3.7	23.4	10.3	4.7	16.1	6.3	7.1	4.3	52.8	49.3	49.1	28.1	12.2	14.7	58.3	38.4	24.0	66.6	49.9	50.2	21.4	56.4	25.9	18.1	42.0	47.2	66.9	34.0	63.2	42.1	58.1	43.9	40.7	36.5	7.6	70.7	38.1	7.8	12.2	50.0	16.8	30.4	28.6	70.3	62.6	21.6	33.3	50.3	93.2	59.2	40.5	29.8	46.1	68.1	61.2	55.3	30.7	47.7	67.5	30.7	62.2	18.2	24.1	30.4	64.4	30.0	13.7	36.9	42.5	50.4	69.5	36.2	51.7	76.9	36.4	51.7	66.1	16.6	5.0	3.6	8.6	8.4	7.6	10.7	10.3	7.4	7.2	9.1	8.0	6.9	5.6	7.9	4.9	6.0	11.4	6.5	3.7	4.4	5.9	4.9	6.0	2.9	3.3	3.2	3.2	3.8	3.7	4.3	4.0	0.0	3.3	4.6	5.6	8.4	6.9	7.1	4.0	4.2	5.2	4.7	3.1	4.3	4.6	9.2	2.1	21.0	4.7	3.6	9.8	8.9	3.0	6.0	6.3	4.3	4.2	45.7	11.8	6.3	25.2	6.4	4.1	6.5	5.7	14.0	3.3	6.0	9.1	1.7	7.3	6.9	4.1	3.2	3.1	2.7	4.1	4.9	0.0	3.7	3.8	9.5	2.1	2.5	5.5	4.1	4.0	8.2	16.4	2.3	3.2	6.6	11.0	6.0	0.0	5.3	8.4	13.4	9.1	9.5	5.4	8.9	7.9	18.7	10.6	4.2
RMI1	"BLAP75, C9orf76, FLJ12888"	ENSG00000178966	"RecQ mediated genome instability 1"	Q9H9A7	9	83980798-84004074	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.0;Late spermatids: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021661			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"		"HPA021661: "	"unprognostic (9.59e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.65e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.24e-2)"	2.5	8.3	2.9	6.0	3.2	3.9	4.5	4.6	3.4	3.2	6.0	6.6	6.2	3.5	5.6	4.9	5.8	2.8	3.4	2.4	5.8	4.4	5.8	3.3	10.2	3.3	3.3	4.4	5.8	7.7	3.7	3.6	3.5	4.8	7.4	7.0	6.0	3.1	3.7	5.1	6.8	3.3	3.2	6.4	6.2	8.9	3.8	10.2	6.0	3.9	9.6	3.6	2.4	3.8	25.2	14.9	33.6	12.4	5.5	7.7	33.9	24.1	13.6	20.7	19.4	7.5	17.0	55.4	8.5	12.4	21.7	36.9	22.0	12.3	25.3	29.2	6.1	23.0	12.1	11.8	7.7	42.6	23.1	7.4	7.8	17.6	12.6	6.7	11.1	28.2	16.7	26.3	23.2	18.1	54.4	17.4	31.3	31.6	15.7	47.8	33.9	21.0	10.8	10.4	30.4	19.3	21.3	18.6	9.8	15.4	19.4	20.8	6.6	22.9	14.7	23.2	20.1	11.6	25.6	20.2	14.6	19.7	26.4	14.2	4.5	8.8	1.8	5.5	2.2	2.8	2.1	1.9	7.2	2.6	2.2	2.5	7.8	2.8	6.5	2.2	3.0	2.6	2.9	3.2	4.6	3.4	2.4	5.8	3.3	3.3	3.5	3.2	3.8	3.8	5.4	9.6	5.1	10.1	5.9	2.7	3.2	4.3	4.0	4.1	4.3	3.3	8.5	2.8	9.0	1.8	4.2	7.9	2.1	6.1	5.9	5.5	70.0	13.9	6.5	3.8	6.7	24.4	7.1	3.0	16.2	3.3	8.2	10.2	4.5	9.0	5.0	13.3	8.1	10.1	11.2	9.8	0.0	10.7	4.3	62.1	2.1	7.4	12.4	8.4	8.5	7.7	5.2	26.2	12.6	2.7	5.6	2.2	7.8	4.2	8.9	4.9	11.1	5.2	0.0	3.3	3.4	34.0	22.6	6.9	4.8	4.2	4.4	7.7	10.1	2.4
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806584-12813640	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 62.3;Extravillous trophoblasts: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	8.9	6.8	7.0	11.8	7.2	28.0	9.0	10.4	9.1	10.8	6.2	10.5	10.3	8.5	4.9	18.3	10.6	4.9	7.6	7.2	6.1	7.4	6.9	7.3	17.1	7.3	6.5	8.9	9.2	5.3	5.4	10.4	7.4	6.0	10.7	8.4	8.6	5.0	8.9	13.9	10.0	8.2	6.0	14.5	9.4	19.8	6.8	24.4	7.5	6.6	18.7	8.2	10.8	9.5	130.0	103.8	94.8	75.7	12.3	23.4	76.2	68.4	40.0	126.3	136.0	76.2	58.7	126.9	106.2	36.6	59.6	79.4	82.6	89.2	83.5	82.7	118.1	67.7	112.9	89.9	7.1	70.6	60.5	10.4	19.7	110.7	43.9	21.4	47.3	114.8	91.2	46.8	82.0	251.4	132.8	83.0	56.4	79.1	167.4	146.1	102.0	113.7	39.6	63.8	119.8	76.7	67.0	39.8	46.7	39.8	76.1	78.4	29.3	129.2	55.7	197.0	126.1	97.6	130.3	108.5	77.4	129.4	105.5	9.4	19.1	17.2	23.9	27.6	23.3	36.8	19.6	22.5	19.0	36.3	15.9	19.6	4.4	44.8	27.7	21.0	25.8	19.1	7.0	7.2	10.4	9.1	7.2	6.1	7.3	6.5	7.4	6.0	6.8	9.5	5.3	0.0	2.6	1.3	15.3	14.0	15.7	22.9	6.8	16.2	2.8	11.7	2.7	12.8	7.6	0.0	4.2	62.3	9.1	11.3	0.0	5.4	16.1	0.8	1.6	9.0	8.4	38.7	2.2	6.0	117.4	10.3	10.7	1.1	3.8	2.5	11.7	4.4	48.9	8.4	3.0	13.9	22.4	9.1	13.2	18.8	8.4	9.3	12.4	1.9	8.5	10.4	14.4	1.0	2.4	2.1	6.8	4.9	33.0	5.3	6.2	1.0	9.5	13.9	6.6	15.6	9.8	51.2	44.9	23.8	13.2	22.7	10.2	0.8	24.8	16.1
SKA2	"FAM33A, FLJ12758"	ENSG00000182628	"Spindle and kinetochore associated complex subunit 2"	Q8WVK7	17	59109857-59155260	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059235	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA059235: AB_2683953"	"unprognostic (2.67e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.93e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.70e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-1)"	19.9	12.6	30.8	20.1	33.4	24.2	11.8	43.3	39.5	18.4	29.1	22.1	18.8	20.3	12.5	24.4	18.1	13.0	34.5	27.8	36.3	21.9	22.4	16.1	33.6	34.3	37.6	16.7	11.5	26.1	14.9	22.9	34.3	16.3	20.0	44.4	10.9	19.9	12.6	13.9	16.8	24.6	37.2	15.8	18.3	12.5	34.4	53.7	25.5	20.4	28.5	20.3	18.1	38.3	217.6	78.6	249.4	85.6	32.4	24.5	76.8	107.1	102.8	163.1	182.5	120.2	122.6	114.1	118.8	87.0	124.3	90.9	162.9	149.3	231.0	197.8	127.4	179.4	142.2	75.1	36.8	142.3	112.5	35.6	63.1	104.8	84.5	64.4	77.2	127.3	114.3	164.5	117.1	297.7	215.4	71.9	66.6	238.3	145.1	114.0	281.3	81.0	121.4	93.2	112.3	96.2	119.1	53.8	66.9	165.4	179.2	112.0	68.0	160.5	153.4	130.5	244.8	111.7	255.6	135.9	85.4	105.3	117.6	26.7	13.1	17.2	18.7	23.5	14.4	18.4	25.6	24.1	15.4	13.7	19.8	22.4	2.4	22.9	38.3	18.3	48.3	12.8	30.8	33.4	43.3	39.5	27.8	36.3	34.3	37.6	34.3	37.2	34.4	38.3	24.8	25.6	18.2	23.2	24.6	21.4	21.6	49.2	25.6	36.1	10.8	17.1	46.3	12.8	26.7	9.2	25.0	62.6	25.8	16.1	39.2	38.3	20.8	22.4	30.2	26.9	10.3	96.8	10.9	25.2	61.7	26.9	30.5	21.0	18.3	26.6	25.4	33.0	46.3	50.5	20.1	23.0	14.2	37.0	22.6	9.4	27.1	28.2	23.2	15.0	42.9	49.3	39.1	15.1	26.3	31.9	24.7	25.6	52.0	8.9	12.8	32.1	26.8	39.4	0.0	13.8	41.5	38.8	30.7	34.1	13.5	30.9	35.0	33.8	35.2	18.9
SKP2	"FBL1, FBXL1, p45"	ENSG00000145604	"S-phase kinase associated protein 2"	Q13309	5	36151989-36196849	"Cancer-related genes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 37.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 134.4;Extravillous trophoblasts: 227.3;Syncytiotrophoblasts: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 274.7;RH-30: 286.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013491, CAB013533, HPA051196, HPA054633"	Approved		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550"	"unprognostic (2.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.72e-7)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.06e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (4.77e-15)"	"unprognostic (2.50e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.19e-1)"	4.9	4.0	3.6	5.8	3.9	11.4	4.9	4.7	4.5	5.9	3.9	6.1	6.3	4.7	4.3	8.3	5.1	2.9	2.5	3.9	3.1	2.3	9.8	4.2	7.9	3.7	3.5	5.2	3.8	2.5	4.0	37.9	3.9	4.0	6.1	4.6	4.0	3.7	2.2	5.7	6.5	4.1	3.9	5.9	4.0	2.6	3.7	12.3	3.1	1.6	8.3	4.7	5.6	5.4	25.4	14.8	35.6	54.3	15.5	20.1	274.7	31.2	25.7	89.5	48.7	83.3	22.8	43.3	10.6	20.0	13.3	28.3	53.3	46.7	71.0	19.2	46.7	23.9	51.4	47.1	6.1	44.8	11.4	18.1	12.2	16.9	8.5	7.7	24.2	40.2	37.9	9.1	31.9	16.4	58.9	26.8	51.5	23.8	24.2	53.7	286.7	28.3	7.2	28.1	45.5	46.8	94.3	27.4	14.1	32.2	22.7	33.3	8.0	31.4	36.1	13.5	24.5	12.4	13.1	50.8	15.2	61.3	21.9	9.2	6.6	13.4	4.2	6.1	6.9	5.2	4.7	4.5	14.0	6.0	6.4	4.6	1.1	6.2	3.2	3.5	4.8	4.7	3.6	3.9	4.7	4.5	3.9	3.1	3.7	3.5	3.9	3.9	3.7	5.4	4.4	22.4	8.9	11.8	8.7	3.7	2.4	7.1	12.0	8.2	3.6	4.2	1.3	1.5	1.7	1.8	10.4	134.4	7.4	2.4	1.9	2.4	0.7	5.2	6.5	6.5	3.0	14.1	22.4	2.9	227.3	11.6	7.1	2.4	2.5	20.9	1.8	11.9	35.0	0.0	13.1	6.0	4.1	9.3	3.1	0.3	4.1	5.3	1.8	12.2	7.6	2.5	9.2	11.6	29.5	2.6	3.4	6.4	10.9	1.0	3.2	1.4	6.2	6.8	0.0	11.5	4.1	1.4	6.4	19.8	4.0	83.9	5.6	11.8	9.6	1.2
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Glandular and luminal cells: 12.4;Spermatocytes: 17.8;Spermatogonia: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046543			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA046543: AB_2679692"	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.0	0.5	0.8	3.0	0.8	10.8	2.9	0.7	1.2	1.1	0.2	4.1	2.9	1.4	1.4	2.5	0.9	1.4	0.6	0.8	0.6	0.7	1.0	0.9	4.9	0.7	0.6	0.8	0.7	0.9	0.4	1.9	0.8	1.3	5.6	1.2	1.7	0.5	0.6	3.1	2.7	1.4	0.4	1.4	1.8	6.6	0.8	9.9	0.9	0.7	5.7	1.1	1.0	1.0	33.7	17.4	24.7	22.1	1.8	3.8	15.7	29.3	14.0	32.0	33.2	18.5	16.1	39.4	13.3	14.4	32.7	21.4	29.4	15.3	33.7	29.6	12.9	44.5	20.9	16.6	0.8	35.7	21.5	1.6	2.1	27.2	17.5	3.8	21.5	29.5	31.7	35.9	24.1	14.3	35.6	10.9	30.0	18.6	14.2	23.0	40.3	19.0	9.0	20.0	22.0	13.2	31.4	22.2	14.6	29.6	14.5	20.6	12.2	29.6	29.9	21.2	40.0	11.9	26.4	38.1	13.8	27.0	28.0	0.3	0.1	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.7	0.0	0.3	0.3	0.1	0.8	0.8	0.7	1.2	0.8	0.6	0.7	0.6	0.8	0.4	0.8	1.0	1.6	3.2	0.5	2.0	2.4	0.9	0.6	2.0	1.2	1.1	2.8	3.0	0.5	0.0	2.3	0.0	4.2	2.5	1.6	5.4	0.0	1.6	1.6	7.8	3.2	2.2	1.8	12.8	5.1	0.4	4.4	1.6	3.1	12.4	2.5	8.2	1.4	0.5	2.9	0.0	3.9	6.1	0.0	2.4	1.2	1.1	0.3	2.7	0.0	0.0	3.0	0.8	1.0	2.0	4.8	1.9	1.8	0.7	10.2	1.1	1.4	0.4	7.6	0.6	0.0	1.7	2.0	17.8	14.4	5.3	2.4	0.8	3.3	2.6	5.5	1.4
TFDP1	"DILC, Dp-1, DP1, DRTF1"	ENSG00000198176	"Transcription factor Dp-1"	Q14186	13	113584721-113641473	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 344.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 31.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033605, HPA044754, HPA068909, HPA077304"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056, HPA077304: "	"unprognostic (4.28e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (5.50e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.57e-4)"	"prognostic favorable (6.17e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	28.2	23.5	24.3	38.6	24.0	164.0	27.2	24.5	24.4	33.5	32.5	37.8	30.5	27.6	19.4	50.1	32.8	24.6	34.3	24.1	22.8	23.2	25.9	21.8	67.1	27.5	24.4	19.3	18.4	28.5	21.3	40.6	25.3	26.1	42.4	20.2	26.1	30.8	58.2	42.8	32.3	34.3	26.6	30.8	31.3	49.6	26.8	53.4	33.1	59.0	68.3	37.5	30.1	25.7	343.2	82.5	104.4	89.5	138.4	122.7	118.5	187.8	168.7	238.1	218.6	173.3	155.9	314.6	61.3	181.3	130.3	160.3	183.0	167.1	232.2	215.9	212.8	184.4	129.2	109.8	86.8	468.3	155.7	102.1	147.3	151.3	87.4	85.0	162.7	116.2	154.1	82.6	215.5	117.7	207.0	181.4	96.6	322.7	105.0	138.9	93.0	181.1	91.3	129.1	268.2	79.3	84.8	228.8	58.7	75.1	157.9	371.7	114.4	77.2	122.9	165.6	210.8	69.5	92.4	326.4	171.9	285.2	133.2	31.9	3.0	4.6	3.1	3.8	3.4	4.4	4.1	3.7	5.9	3.6	6.3	3.2	3.8	2.3	5.5	3.0	5.3	2.5	24.3	24.0	24.5	24.4	24.1	22.8	27.5	24.4	25.3	26.6	26.8	25.7	21.4	9.6	15.8	12.7	38.8	59.8	32.1	16.1	33.6	10.3	45.6	35.2	26.6	28.6	14.7	29.5	14.6	83.2	33.8	29.8	80.3	12.3	5.5	34.4	28.2	25.8	40.2	344.3	22.5	11.9	128.0	30.8	38.7	31.0	21.0	23.3	34.6	58.7	49.2	6.7	19.5	36.1	12.2	49.1	51.2	10.7	28.6	41.1	35.6	5.6	24.8	14.7	16.5	9.5	10.2	19.0	24.2	28.2	67.3	35.7	29.4	66.5	21.0	22.5	6.6	20.0	32.7	76.7	52.7	74.6	60.0	66.6	32.1	30.3	47.4	35.8
TIMELESS	"hTIM, TIM, TIM1"	ENSG00000111602	"Timeless circadian regulator"	Q9UNS1	12	56416363-56449426	"Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.5;Spermatogonia: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA060655	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA060655: AB_2684338"	"unprognostic (3.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.03e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (9.47e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.01e-2)"	3.4	3.4	1.6	11.0	2.1	22.0	4.5	2.1	2.1	4.1	2.7	6.7	6.0	4.4	2.5	6.8	3.1	3.3	1.8	1.5	2.1	3.8	9.8	4.1	15.3	2.4	2.4	1.9	5.0	5.9	5.4	8.7	2.5	3.2	8.5	13.7	3.9	3.4	3.4	5.5	6.2	5.6	2.1	6.8	5.5	6.2	2.6	19.8	4.7	1.6	17.9	4.7	3.9	2.5	39.4	89.1	111.4	51.9	9.9	9.9	62.8	41.9	25.3	58.3	46.0	45.6	56.5	113.3	41.5	24.5	29.4	32.8	82.0	32.7	53.5	54.2	45.7	86.9	47.6	33.6	5.1	66.2	62.2	6.9	10.3	41.9	25.2	16.0	31.5	67.3	82.7	99.5	49.8	77.2	94.7	51.2	79.2	49.5	36.8	93.5	56.7	55.5	22.7	49.5	85.4	58.9	78.2	43.9	12.2	45.6	77.4	51.8	18.9	45.3	45.1	41.8	35.0	37.3	50.9	62.8	21.1	39.9	55.5	0.1	0.6	0.4	1.8	1.5	0.3	3.3	1.1	1.2	1.0	4.9	0.8	0.3	0.2	1.5	1.1	1.2	1.5	1.1	1.6	2.1	2.1	2.1	1.5	2.1	2.4	2.4	2.5	2.1	2.6	2.5	2.6	0.0	5.0	2.3	8.2	3.3	3.0	3.0	6.8	57.5	3.1	3.4	2.1	2.8	6.8	7.3	2.1	15.9	1.8	2.7	0.0	4.8	6.9	2.5	3.9	5.0	1.8	16.6	0.9	5.7	20.9	3.7	6.6	4.8	5.7	15.5	4.6	10.6	8.5	6.7	1.3	5.2	4.1	2.6	3.7	2.9	1.2	4.6	0.0	1.9	4.2	4.8	4.1	0.5	3.2	3.7	0.6	1.2	18.2	4.2	1.1	2.0	3.4	17.8	0.0	2.7	7.0	1.6	24.5	12.1	1.4	9.2	6.1	3.2	8.5	3.0
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174091-78187233	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Erythroid cells: 108.6;Extravillous trophoblasts: 210.4;Hofbauer cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 34.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"white matter: 3.6"	"Low region specificity"	"Detected in many"			CAB004683	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.87e-4)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	3.7	2.7	2.5	20.4	3.4	77.9	5.9	3.6	3.4	5.9	1.3	24.4	18.0	3.0	0.2	27.2	4.9	3.4	2.8	2.7	2.4	11.0	9.2	9.1	34.8	3.4	3.3	1.3	5.6	0.6	0.6	14.8	3.3	3.4	15.7	0.1	6.3	1.5	5.5	14.2	18.3	10.1	2.6	12.4	17.9	3.1	3.8	25.1	2.0	1.6	30.6	5.5	9.0	4.4	443.9	357.7	68.2	92.5	7.6	28.0	47.3	207.6	113.2	323.1	442.3	324.2	178.7	144.1	72.9	131.7	133.9	204.2	63.4	187.1	158.0	51.2	230.4	252.5	119.9	213.3	2.2	107.1	162.9	13.8	7.1	166.1	22.5	22.3	137.9	49.4	156.7	311.9	130.8	352.0	56.0	68.6	36.7	259.1	240.9	152.6	276.4	324.1	90.6	138.5	33.6	94.2	162.0	481.2	59.7	59.4	303.9	156.1	57.8	302.3	305.7	219.9	292.1	132.5	71.4	181.9	149.0	71.9	142.1	0.0	1.1	0.0	1.8	2.1	0.7	5.8	7.9	4.0	3.4	1.7	0.4	2.2	1.8	10.8	1.7	1.1	34.0	5.5	2.5	3.4	3.6	3.4	2.7	2.4	3.4	3.3	3.3	2.6	3.8	4.4	1.6	0.0	2.7	0.0	17.1	28.4	13.3	17.8	2.2	0.0	10.6	9.4	0.9	2.8	8.3	12.9	0.0	92.8	3.6	35.0	7.9	7.7	3.0	9.2	3.3	10.6	5.4	108.6	0.3	11.2	210.4	15.7	19.4	7.0	0.0	15.9	7.5	10.5	65.2	0.0	0.2	32.7	8.2	15.5	19.1	6.8	0.6	10.9	3.6	0.0	5.7	0.0	3.1	0.0	1.0	9.6	7.5	0.7	53.6	4.9	3.1	17.5	5.8	0.0	0.0	1.7	20.1	3.8	16.8	24.7	11.2	51.0	8.7	1.7	60.8	24.0
TMLHE	"BBOX2, FLJ10727, TMLH, XAP130"	ENSG00000185973	"Trimethyllysine hydroxylase, epsilon"	Q9NVH6	X	155489011-155719098	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 51.5;Oligodendrocyte precursor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA034589, HPA040331"	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA034589: AB_10670571, HPA040331: AB_2676929"	"unprognostic (1.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-3)"	"unprognostic (6.97e-2)"	"prognostic favorable (3.68e-6)"	"unprognostic (1.69e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.75e-2)"	11.7	10.2	7.1	6.6	7.4	8.4	11.3	9.0	8.0	11.3	8.1	11.6	11.8	9.4	10.4	10.3	9.9	8.0	25.3	6.7	7.7	16.7	18.8	5.6	7.0	8.5	8.2	12.0	9.5	18.9	5.4	8.4	8.5	6.6	12.5	10.9	12.7	9.7	32.0	5.9	11.2	12.3	8.3	8.7	9.1	2.9	7.3	8.9	10.5	33.4	7.6	8.2	6.6	9.8	25.0	11.9	9.8	28.6	11.8	18.1	0.0	9.9	14.6	12.3	32.4	8.7	13.9	0.0	38.9	17.6	28.2	13.4	21.2	9.7	13.9	10.3	14.3	11.3	19.5	10.2	16.4	10.5	7.6	19.5	20.0	13.6	20.8	18.2	19.5	15.5	15.8	9.0	20.5	9.3	12.8	11.8	3.0	21.6	0.1	12.7	15.5	9.4	15.0	8.5	9.2	13.7	9.3	0.5	11.2	10.5	10.6	11.9	16.5	10.3	9.7	20.4	12.4	11.0	12.6	9.6	12.4	16.4	9.6	3.4	12.6	14.7	4.6	14.9	3.5	8.1	5.0	3.9	13.1	10.6	6.5	5.7	18.2	6.2	21.5	6.1	5.5	5.8	7.1	7.4	9.0	8.0	6.7	7.7	8.5	8.2	8.5	8.3	7.3	9.8	6.7	0.0	2.3	27.1	10.1	5.2	12.1	14.4	9.6	4.0	5.2	7.5	7.2	7.2	9.7	9.2	0.0	8.8	6.5	7.9	23.5	10.7	0.0	6.8	7.4	6.2	6.1	14.3	22.2	7.6	6.8	10.2	9.2	7.3	10.1	8.1	4.2	12.0	12.4	0.0	29.5	7.3	4.1	16.1	10.4	0.5	8.4	12.1	12.4	51.5	13.1	7.6	10.3	47.7	25.5	8.5	7.3	5.7	5.6	4.3	17.4	17.0	9.5	5.4	0.0	5.9	9.5	0.3	2.5	7.6	4.1	6.7	8.0	10.5	6.5	11.0
TONSL	"IKBR, NFKBIL2"	ENSG00000160949	"Tonsoku like, DNA repair protein"	Q96HA7	8	144428775-144444440	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.5"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024679, HPA046494"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nuclear bodies"	"HPA024679: AB_1854441, HPA046494: AB_2679673"	"unprognostic (6.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.04e-3)"	"unprognostic (7.81e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.11e-3)"	"unprognostic (7.96e-2)"	1.0	2.1	0.4	2.5	0.4	8.5	1.3	0.4	1.3	1.7	0.0	3.4	3.5	1.6	0.2	3.9	1.4	0.6	1.4	0.3	0.3	1.4	1.7	1.3	2.3	1.3	0.6	1.7	1.5	0.4	0.9	1.5	1.1	1.6	0.8	0.1	1.5	0.8	0.5	3.3	4.4	0.6	0.1	3.9	2.2	3.8	0.8	2.3	2.4	0.1	1.4	2.3	2.1	0.3	21.2	18.6	13.7	21.7	1.0	1.7	33.0	17.6	3.4	10.4	8.1	15.0	17.9	19.6	17.5	2.7	4.9	14.2	13.4	10.7	2.3	20.2	26.6	46.5	26.1	15.9	0.6	14.3	28.1	1.7	1.5	10.9	2.1	2.6	5.0	26.5	53.0	14.3	4.2	43.4	35.5	24.5	19.4	20.4	26.7	42.6	8.9	20.3	5.9	22.6	22.9	13.0	18.4	12.3	7.8	5.2	17.6	13.2	5.9	12.7	52.3	14.5	21.7	5.0	9.9	12.0	12.3	30.2	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.4	1.3	0.3	0.3	1.3	0.6	1.1	0.1	0.8	0.3	2.5	6.4	22.4	1.6	2.9	8.9	5.2	1.0	1.2	3.1	3.5	2.9	2.3	8.6	3.7	1.8	2.1	4.1	1.3	20.2	0.0	0.9	0.4	4.3	2.7	4.3	2.4	7.2	2.4	1.0	5.3	3.8	11.7	6.1	2.5	8.5	2.9	11.4	4.5	1.7	1.0	14.6	0.0	0.9	16.7	0.7	0.3	3.0	14.2	1.9	1.2	1.1	1.0	0.5	0.8	1.2	7.1	1.2	4.0	3.9	76.5	7.7	4.1	3.0	6.6	6.4	2.8	4.6	7.8	3.4	11.2	1.2	3.1	3.3	15.9	3.9
TRIM59	"Mrf1, RNF104, TRIM57, TSBF1"	ENSG00000213186	"Tripartite motif containing 59"	Q8IWR1	3	160432445-160485773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 68.4"	"Cell type enriched"	"Detected in many"	12	"Oligodendrocytes: 391.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017750	Uncertain		Approved	"Rods & Rings"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Rods & Rings"		"HPA017750: AB_1858312"	"unprognostic (3.74e-1)"	"prognostic favorable (4.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.00e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.02e-3)"	"unprognostic (2.44e-11)"	"unprognostic (7.92e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.91e-3)"	0.7	0.8	9.0	5.1	38.8	17.6	2.1	18.0	20.4	1.4	0.0	2.7	2.8	3.0	0.9	4.9	2.0	2.7	0.8	12.3	15.2	1.2	1.0	2.0	12.1	19.4	23.6	1.3	1.5	1.8	1.2	2.0	19.9	2.0	2.6	1.4	1.7	1.0	1.2	5.4	2.9	2.8	9.3	5.1	2.5	8.7	24.6	13.6	2.0	0.1	12.1	3.1	2.2	68.4	20.4	15.8	19.8	1.3	7.8	10.6	26.0	31.5	27.3	38.5	36.9	1.9	34.8	54.5	22.9	23.7	12.1	34.1	0.0	12.9	50.7	49.1	19.2	2.0	5.4	2.4	10.9	24.3	3.2	9.0	3.8	18.7	13.4	23.6	27.1	8.0	25.8	22.6	36.7	21.9	15.0	1.9	52.5	13.2	26.1	20.7	17.2	24.6	13.8	6.6	13.0	2.8	9.0	26.3	0.7	26.5	31.2	22.4	20.9	2.8	8.9	4.5	3.1	37.0	14.5	13.4	3.4	31.0	3.1	29.1	2.8	5.4	10.9	3.1	12.7	10.4	17.9	15.0	4.5	9.3	12.0	14.5	2.2	12.4	1.5	6.7	22.0	3.7	9.0	38.8	18.0	20.4	12.3	15.2	19.4	23.6	19.9	9.3	24.6	68.4	0.6	0.0	6.5	0.3	7.8	4.8	4.7	2.1	3.4	0.4	2.8	1.8	2.5	2.8	1.4	1.8	6.2	7.2	6.1	1.2	0.0	2.0	31.2	1.9	2.1	2.5	10.8	29.5	0.4	2.0	11.7	2.1	5.1	2.9	1.3	10.1	2.2	0.1	2.9	0.0	0.5	2.9	2.0	2.2	2.3	12.5	0.3	1.8	3.6	0.0	2.1	0.5	3.1	0.0	391.8	1.9	2.8	0.7	6.4	3.3	1.2	2.3	2.1	1.7	0.0	2.4	2.7	14.0	15.1	5.6	4.4	2.5	10.9	2.7	4.8	3.6
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657653-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.5;lymphoid tissue: 113.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 105.8;Erythroid cells: 189.3;Extravillous trophoblasts: 115.3;Plasma cells: 112.7;Spermatocytes: 180.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.7;T-cells: 14.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002784, HPA074922"	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB002784: , HPA074922: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	4.5	3.1	4.3	24.2	7.5	88.5	6.7	4.1	6.5	4.8	2.7	22.9	10.5	5.1	1.3	14.8	5.6	3.8	2.2	5.0	4.9	6.5	11.8	4.9	36.1	4.9	5.2	2.1	3.6	1.8	1.6	22.3	4.4	3.1	27.1	4.2	3.9	2.0	0.4	6.2	14.8	12.7	4.8	10.6	8.8	34.3	6.1	113.6	2.1	0.4	44.5	8.4	5.5	10.3	102.7	156.6	320.4	154.9	35.1	57.9	159.9	238.9	141.1	251.7	299.9	132.8	80.1	160.0	91.5	129.9	143.2	45.1	225.3	89.7	216.1	152.3	244.9	273.1	135.8	229.4	8.2	564.8	286.5	51.5	20.7	159.6	49.6	48.4	214.4	334.0	222.0	249.6	321.8	118.1	687.7	311.4	114.7	124.3	114.0	446.8	287.0	191.3	95.6	88.9	106.0	175.7	201.4	91.6	61.1	197.3	63.5	253.5	85.0	289.7	569.5	267.3	474.2	305.9	405.2	367.3	75.2	240.6	339.2	0.0	0.0	1.3	1.1	0.1	0.0	1.1	2.8	2.2	1.8	0.0	0.0	0.6	0.7	6.7	0.1	0.3	14.1	2.9	4.3	7.5	4.1	6.5	5.0	4.9	4.9	5.2	4.4	4.8	6.1	10.3	2.1	0.0	2.3	1.6	15.7	14.4	15.9	13.0	27.9	0.5	7.8	11.7	3.6	2.8	6.7	0.0	0.0	105.8	14.5	15.5	1.9	2.3	34.4	5.6	8.4	12.5	1.2	189.3	0.4	0.8	115.3	28.3	14.3	7.4	7.0	76.2	6.8	4.3	71.4	0.0	0.6	20.9	10.2	15.6	19.4	31.9	6.2	10.7	10.6	1.0	3.9	45.0	5.2	0.5	15.6	1.5	8.9	3.8	112.7	5.0	13.8	36.6	1.0	2.4	13.1	1.3	32.6	180.8	30.7	48.0	7.2	27.0	21.3	10.5	54.9	18.7
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 27.0;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 49.7;Plasma cells: 21.0;Squamous epithelial cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.8;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 450.9;REH: 1004.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	1.0	0.9	2.1	9.6	2.7	27.0	1.7	2.1	2.3	1.6	1.8	2.9	3.7	1.0	0.1	6.5	0.4	0.8	0.5	2.0	2.2	0.6	0.9	1.3	15.8	2.8	2.8	0.3	0.6	0.2	0.2	2.1	2.7	0.6	2.6	0.4	1.5	0.2	1.2	3.4	3.9	1.9	1.9	3.7	3.3	5.2	3.5	67.2	0.3	0.3	10.3	1.6	2.5	4.6	111.3	78.7	116.6	83.4	3.3	13.3	18.5	88.3	42.0	89.9	86.8	94.6	54.9	62.7	21.1	39.4	32.7	54.1	81.2	47.7	63.0	102.7	92.2	54.3	74.3	102.4	1.3	135.1	78.9	6.5	3.5	48.9	12.6	14.1	27.2	97.2	79.3	70.5	54.5	86.7	450.9	82.5	52.5	40.0	84.3	1004.5	259.7	45.4	24.9	80.1	86.0	68.5	69.2	37.7	12.1	18.8	68.2	127.6	34.2	94.6	76.7	124.3	108.3	29.8	33.1	183.5	54.8	129.7	123.3	0.3	0.2	0.1	0.6	0.0	0.0	0.2	0.8	1.0	1.3	0.1	0.2	0.8	0.8	0.5	0.2	4.8	2.3	0.6	2.1	2.7	2.1	2.3	2.0	2.2	2.8	2.8	2.7	1.9	3.5	4.6	0.2	0.0	0.0	1.6	2.1	0.0	0.8	0.0	3.4	2.5	4.4	2.8	4.3	1.5	0.6	0.0	0.0	6.6	6.9	2.6	0.0	2.2	2.9	1.3	1.8	2.2	0.0	49.7	0.4	0.4	7.8	4.7	8.6	2.4	0.0	10.4	0.4	0.7	8.9	3.3	0.4	2.3	0.0	1.9	0.0	1.8	0.6	3.8	0.0	0.0	2.0	0.6	1.0	3.0	1.3	4.2	1.9	0.4	21.0	0.6	1.4	0.2	0.7	0.7	0.0	1.2	6.1	6.1	11.9	15.8	0.0	1.4	3.7	1.5	8.3	1.3
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641970-115698224	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.3;NK-cells: 6.2;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB076375: AB_2665604, HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	4.9	3.9	2.1	3.8	1.2	2.5	3.2	0.8	1.1	9.1	3.0	6.8	3.8	5.5	4.9	10.4	12.0	3.8	5.4	1.3	1.3	5.3	3.0	4.1	2.1	1.2	3.0	4.4	5.0	5.2	0.5	3.6	1.7	4.4	6.4	1.6	6.4	4.5	0.9	6.8	3.9	7.3	1.2	2.2	5.5	5.0	6.5	7.3	7.6	2.4	2.5	6.4	4.4	1.0	49.6	20.7	6.6	8.9	24.1	21.5	13.1	18.8	13.5	24.1	19.1	12.0	24.1	0.0	31.5	21.9	22.7	60.9	11.2	33.3	15.8	57.9	13.7	27.4	18.4	9.8	8.8	8.2	11.4	11.4	23.1	17.2	18.2	12.8	24.1	45.9	16.8	14.8	24.5	65.7	41.0	3.4	16.7	28.8	19.5	0.1	19.1	14.3	11.0	32.8	5.9	8.0	33.9	22.2	15.4	12.4	11.3	8.8	26.2	16.5	25.7	36.3	34.6	2.1	2.3	0.2	22.3	14.3	41.1	0.0	0.5	0.0	1.9	0.3	0.5	0.2	1.2	1.9	2.3	0.0	0.4	2.0	0.0	6.2	0.5	2.0	3.0	1.0	2.1	1.2	0.8	1.1	1.3	1.3	1.2	3.0	1.7	1.2	6.5	1.0	9.2	3.2	3.2	5.5	0.5	7.4	7.4	16.8	11.4	5.2	4.6	4.6	7.9	2.8	9.6	9.2	39.6	5.0	3.4	11.2	0.0	15.7	6.1	25.1	7.7	10.5	6.7	13.2	0.9	13.8	7.3	10.1	8.2	17.0	0.0	5.1	28.9	2.5	4.3	0.0	0.7	8.6	10.2	1.9	1.4	3.0	5.9	2.9	0.0	4.7	11.1	4.7	9.2	2.0	0.1	20.8	6.1	8.2	1.8	8.3	2.6	5.6	12.8	0.9	6.6	4.3	8.5	5.5	7.0	20.0	6.5	0.4	3.1	3.2	10.3	6.5
VPS45	"h-vps45, H1, VPS45A, VPS45B"	ENSG00000136631	"Vacuolar protein sorting 45 homolog"	Q9NRW7	1	150067279-150145329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.8;Late spermatids: 267.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027425, HPA027441"	Uncertain		Approved	Microtubules		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	Microtubules		"HPA027425: AB_10599415, HPA027441: AB_10602284"	"unprognostic (1.57e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.36e-3)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (4.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-2)"	19.1	26.8	32.3	12.0	34.6	6.6	17.8	40.2	43.0	20.1	27.7	22.0	12.6	18.7	22.5	16.7	16.1	13.7	38.6	34.0	33.2	21.1	12.5	15.4	13.5	30.6	31.4	14.0	11.1	26.4	19.1	17.3	31.5	18.8	17.2	29.2	14.3	20.1	19.3	16.5	15.3	25.2	31.5	16.2	17.4	11.0	32.9	17.0	19.8	16.6	15.3	18.5	15.9	32.8	31.5	24.3	40.9	27.0	37.1	29.4	19.0	44.7	23.7	45.3	37.4	17.7	26.1	19.3	26.5	37.0	19.9	26.0	42.4	27.0	49.0	38.7	31.1	24.6	33.5	16.8	24.7	17.6	30.2	25.8	24.8	43.5	22.8	29.7	37.1	38.6	34.4	28.3	40.0	53.5	34.7	17.5	28.4	28.7	38.4	23.7	41.9	27.4	31.2	30.0	28.5	59.7	34.9	29.8	46.9	46.2	48.9	45.6	32.6	20.8	25.1	18.7	31.3	21.3	49.4	18.9	30.9	24.4	30.2	23.6	26.6	4.7	16.0	28.0	15.0	15.6	13.6	15.1	25.9	12.8	13.2	13.9	2.5	14.1	19.9	14.6	16.8	18.4	32.3	34.6	40.2	43.0	34.0	33.2	30.6	31.4	31.5	31.5	32.9	32.8	9.4	12.8	14.0	85.8	11.9	7.4	8.2	12.7	13.1	20.9	11.0	10.2	44.0	8.6	11.0	16.5	18.8	20.9	12.5	8.3	7.9	12.3	202.8	9.7	14.2	10.4	7.8	4.6	79.4	7.2	9.5	14.7	12.8	10.1	6.3	24.6	12.1	7.2	19.0	30.3	90.2	8.1	14.2	18.0	8.6	267.9	21.5	13.6	10.6	45.9	19.7	17.9	6.2	92.5	59.5	11.4	11.6	14.7	8.4	6.4	13.6	9.2	11.5	23.8	32.9	7.3	17.1	18.1	15.1	11.6	7.7	14.8	11.2	21.2	9.7	7.9
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938949-55027105	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 15.5;Spermatocytes: 15.0;Spermatogonia: 19.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	1.3	0.8	0.5	3.8	1.0	7.2	2.2	0.9	0.9	1.2	0.1	2.8	1.8	2.1	0.6	2.4	1.6	1.3	0.9	0.7	0.2	1.1	1.2	1.3	5.5	0.2	0.2	1.4	0.9	1.5	0.3	2.8	0.2	1.0	4.0	1.8	0.7	0.8	0.6	2.0	1.7	2.6	0.3	1.7	1.6	5.3	0.4	8.0	0.9	0.8	6.7	1.7	1.1	0.9	39.6	24.7	48.4	21.4	4.6	11.2	28.1	37.5	16.1	29.6	36.0	16.6	25.9	44.9	18.6	10.8	21.4	32.8	72.9	21.5	61.7	30.0	12.7	29.8	23.7	16.2	1.9	56.7	21.8	5.9	3.8	36.6	14.3	7.1	19.6	28.8	37.8	22.0	28.7	21.7	53.5	11.1	38.6	21.1	25.7	49.5	69.7	17.3	8.4	26.0	28.1	19.8	39.8	10.0	12.8	35.1	26.8	11.3	12.8	37.3	43.9	27.5	32.1	6.5	14.4	58.8	17.1	27.4	30.0	1.7	0.3	0.6	0.9	0.2	1.2	1.2	1.0	1.3	0.5	1.8	1.3	1.8	0.4	2.0	0.4	0.7	1.6	0.6	0.5	1.0	0.9	0.9	0.7	0.2	0.2	0.2	0.2	0.3	0.4	0.9	2.3	0.0	2.0	3.9	5.1	3.8	2.2	3.5	3.4	2.9	1.8	1.9	1.7	0.0	4.0	3.7	0.0	8.7	3.6	1.8	0.0	1.8	0.8	1.9	3.1	2.0	0.0	15.5	10.3	1.0	8.4	3.4	2.6	2.5	0.0	12.4	0.7	0.9	4.1	3.3	6.5	2.4	6.1	2.1	1.2	1.1	0.0	2.4	1.8	5.6	1.4	1.4	2.1	4.5	10.1	1.1	0.3	3.0	7.8	0.6	0.5	6.2	3.5	3.1	0.0	2.4	3.0	15.0	19.3	6.1	2.4	2.6	3.6	2.8	5.2	1.7
WDR76	FLJ12973	ENSG00000092470	"WD repeat domain 76"	Q9H967	15	43826980-43868412	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.1;lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 35.3;Spermatocytes: 23.5;Spermatogonia: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039804, HPA040626"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear bodies"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Nucleoli fibrillar center"	"HPA039804: AB_10795297, HPA040626: AB_10795527"	"unprognostic (2.26e-1)"	"unprognostic (7.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (6.98e-4)"	"prognostic unfavorable (8.02e-5)"	"unprognostic (4.24e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (1.35e-8)"	"unprognostic (7.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.28e-2)"	2.6	1.2	1.0	8.4	1.1	19.1	3.5	4.8	1.7	3.0	0.8	4.8	3.2	3.3	0.9	4.5	1.7	1.9	1.1	0.7	1.1	1.5	2.2	2.4	19.8	1.3	1.1	2.2	3.1	2.7	1.1	3.9	1.3	1.9	6.0	6.3	2.4	2.0	0.8	4.1	3.3	3.9	1.0	3.6	2.9	5.3	1.3	19.5	2.5	1.3	21.3	2.8	2.8	1.2	35.1	17.5	40.7	31.3	4.5	10.7	11.1	57.3	33.9	61.5	76.8	22.1	17.8	51.4	24.8	26.9	31.0	49.4	42.4	20.5	53.1	80.4	25.2	63.3	52.1	7.3	2.5	65.0	27.0	3.4	3.3	33.8	7.7	8.9	19.9	54.7	48.6	86.9	42.6	12.2	63.4	15.4	14.6	11.0	18.1	66.9	70.1	32.4	11.4	35.5	31.3	30.9	36.1	22.5	7.0	12.6	35.0	31.0	9.1	56.3	26.5	63.5	58.9	42.7	114.6	129.1	40.4	56.7	31.5	0.0	0.6	0.3	3.8	0.5	4.1	1.8	4.6	3.4	1.0	2.2	3.8	2.9	0.0	4.8	0.2	1.2	6.6	2.0	1.0	1.1	4.8	1.7	0.7	1.1	1.3	1.1	1.3	1.0	1.3	1.2	4.1	3.2	1.3	2.6	8.2	7.4	3.2	2.4	4.6	3.7	3.7	2.8	1.2	1.5	2.3	1.8	10.4	12.8	6.2	3.5	1.9	2.9	1.7	1.8	3.9	4.8	0.0	35.3	2.5	4.2	13.0	3.9	4.6	3.3	5.7	12.2	2.9	0.9	8.9	1.7	3.3	3.7	0.0	3.5	5.3	0.9	1.8	3.9	3.6	2.8	3.3	8.0	10.3	0.5	1.9	1.1	3.1	2.2	16.1	1.5	1.4	0.9	0.4	16.2	6.6	5.8	5.7	23.5	35.9	7.4	5.8	3.6	11.6	1.5	9.0	1.8
XRCC2	FANCU	ENSG00000196584	"X-ray repair cross complementing 2"	O43543	7	152644776-152676141	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 14.1;Extravillous trophoblasts: 21.2;Granulosa cells: 20.2;Spermatocytes: 31.3;Spermatogonia: 19.1;Syncytiotrophoblasts: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065153			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Vesicles"		"HPA065153: AB_2685422"	"unprognostic (9.31e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.36e-5)"	"unprognostic (9.98e-3)"	"unprognostic (5.82e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-15)"	"unprognostic (4.52e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.73e-2)"	0.2	0.2	0.9	2.3	0.6	5.3	1.5	1.6	2.8	0.3	0.0	1.1	1.7	1.1	0.9	1.0	0.5	0.4	1.0	0.6	1.9	0.4	0.4	0.5	2.9	0.6	0.6	1.0	0.0	0.6	0.0	2.1	1.4	0.7	1.7	1.9	0.2	0.4	0.1	1.9	1.5	0.5	1.1	1.0	1.0	3.0	1.0	3.6	0.6	0.0	2.5	0.5	0.1	1.9	16.5	10.4	18.3	15.8	1.1	1.8	15.0	11.8	3.9	8.2	10.3	14.7	12.8	24.8	9.5	3.5	13.7	13.7	12.8	7.1	19.3	8.9	17.3	16.8	15.5	10.0	0.3	27.3	9.3	0.9	1.1	15.6	3.6	2.0	3.8	15.5	34.2	22.8	8.3	12.6	32.4	21.2	21.6	10.8	12.9	22.8	19.3	15.3	3.1	10.3	16.7	18.1	11.7	7.6	5.0	11.3	5.4	8.3	4.2	17.2	6.9	13.3	23.0	8.8	14.5	19.0	11.0	20.9	20.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.6	1.6	2.8	0.6	1.9	0.6	0.6	1.4	1.1	1.0	1.9	0.2	0.0	1.1	1.6	1.9	1.3	1.0	1.0	0.0	4.9	0.8	0.4	2.9	0.0	1.4	1.8	0.0	11.2	0.4	0.9	0.0	1.1	11.7	0.9	1.9	1.1	0.0	14.1	2.3	0.2	21.2	2.5	3.1	1.4	0.0	20.2	1.1	0.2	2.4	0.0	2.0	1.7	2.0	0.6	0.8	4.9	0.9	0.8	0.0	0.0	0.6	1.1	3.1	4.5	2.0	0.5	0.1	1.2	6.1	0.6	0.3	0.3	0.1	2.3	0.0	1.9	1.8	31.3	19.1	2.7	1.4	12.6	2.2	1.2	2.3	1.0
ZNF367	FLJ33970	ENSG00000165244	"Zinc finger protein 367"	Q7RTV3	9	96385941-96418370	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA015319, HPA015785"	Uncertain		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA015319: AB_2669185, HPA015785: AB_2217750"	"unprognostic (5.91e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.76e-3)"	"unprognostic (1.60e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.88e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.34e-4)"	"unprognostic (2.28e-1)"	1.4	0.6	0.7	3.7	1.3	26.1	1.7	1.4	1.3	1.1	0.2	3.0	2.9	1.1	0.1	2.4	0.7	1.0	2.1	0.7	1.0	3.0	10.8	1.1	4.6	1.5	1.4	1.0	1.4	1.6	0.3	1.9	1.4	1.2	3.3	1.3	0.7	0.4	1.5	3.5	3.0	2.4	0.9	1.3	2.1	6.1	1.3	8.7	1.1	2.7	4.7	1.5	1.2	2.7	25.4	10.3	9.9	8.9	3.8	5.3	13.4	34.6	20.4	16.9	20.0	6.4	17.5	19.2	14.4	16.5	12.6	30.5	11.6	12.6	19.9	21.2	10.0	14.0	19.1	5.3	0.0	19.8	16.5	0.9	0.8	13.7	6.9	3.7	6.3	13.3	13.0	45.4	21.7	16.9	30.4	16.1	6.7	27.9	16.7	15.3	49.9	11.7	4.9	16.8	17.4	12.0	15.3	18.1	10.6	8.0	9.4	17.3	5.7	27.6	15.8	25.6	26.6	17.6	32.0	7.8	16.7	17.0	23.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.7	1.3	1.4	1.3	0.7	1.0	1.5	1.4	1.4	0.9	1.3	2.7	1.1	0.0	0.0	2.9	3.8	9.9	1.3	0.4	10.8	0.7	2.2	2.3	2.6	0.0	0.9	0.0	0.0	3.2	2.5	2.4	0.0	0.5	0.7	0.6	1.1	2.0	0.0	22.3	5.1	1.2	4.2	1.7	2.6	1.8	0.0	4.7	1.1	3.8	1.9	0.0	5.3	3.6	0.0	2.1	2.6	0.8	0.6	8.3	3.6	2.8	0.1	0.6	1.0	3.0	7.9	0.7	0.5	0.7	9.6	0.6	0.9	2.5	0.0	1.5	6.6	2.0	3.6	10.3	1.7	10.9	6.5	0.8	5.0	0.3	5.6	1.1